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Abstract  
P-cadherin serves as a major topobiological cue in mammalian epithelium. In human hair 
follicles (HFs), it is prominently expressed in the inner hair matrix that harbors the HF 
pigmentary unit. However, the role of P-cadherin in normal human pigmentation remains 
unknown. Since patients with mutations in the gene that encodes P-cadherin show 
hypotrichosis and fair hair, we explored the hypothesis that P-cadherin may control HF 
pigmentation. When P-cadherin was silenced in melanogenically active organ-cultured human 
scalp HFs, this significantly reduced HF melanogenesis and tyrosinase activity as well as 
gene and/or protein expression of gp100, stem cell factor, c-Kit, and microphthalmia-
associated transcription factor (MITF), both in situ and in isolated human HF melanocytes. 
Instead, epidermal pigmentation was unaffected by P-cadherin knockdown in organ-cultured 
human skin. In hair matrix keratinocytes, P-cadherin silencing reduced plasma membrane β-
catenin, while glycogen synthase kinase 3 beta (GSK3β) and phospho-β-catenin expression 
were significantly upregulated. This suggests that P-cadherin-GSK3β/Wnt signaling is 
required for maintaining expression of MITF to sustain intrafollicular melanogenesis. Thus, P-
cadherin-mediated signaling is a novel, melanocyte subtype-specific topobiological regulator 
of normal human pigmentation, possibly via GSK3β-mediated canonical Wnt signaling.  
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Introduction   
 
Like other intercellular adhesion molecules, P-cadherin serves as an important topobiological 
tissue cue (Edelman, 1989; Engler et al., 2009), that regulates cell-cell recognition and 
signaling, namely during epithelial morphogenesis, hair growth and tumor development 
(Bauer and Bosserhoff, 2006; Borghi and James Nelson, 2009; Edelman, 1989; Fanelli et al., 
2008; Goodwin and Yap, 2004; Hirai et al., 1989; Paredes et al., 2007; Taneyhill, 2008; Van 
Marck et al., 2005). As a transmembrane glycoprotein composed of 5 extracellular domains 
that promote calcium ion-dependent cell-cell adhesion of adjacent keratinocytes P-cadherin 
forms a major component of adherens junctions (Fanelli et al., 2008; Nagafuchi et al., 1987; 
Takeichi, 1991; Takeichi et al., 1988). Selective P-cadherin expression thus connects defined 
epidermal and hair follicle (HF) keratinocyte populations into functional epithelial units 
(Horiguchi et al., 1994; Muller-Rover et al., 1999; Shimoyama et al., 1989a; Shimoyama et al., 
1989b).  
The intracellular domain of P-cadherin interacts with p-120 catenin and β-catenin, which 
through α-catenin, anchors the adherens junctions to the actin cytoskeleton (Fanelli et al., 
2008; Furukawa et al., 1997). Since cadherin-mediated cell adhesion and the canonical Wnt 
signaling depend on the same pool of β-catenin, P-cadherin may influence the canonical Wnt 
signaling pathway (for details see Supplementary Text S1) which is involved in many 
developmental processes (Dann et al., 2001; Fanelli et al., 2008; Linker et al., 2005; Nelson 
and Nusse, 2004) including the development of both, normal melanocytes and malignant 
melanoma (Bellei et al., 2010; Schepsky et al., 2006; Takeda et al., 2000; Yamaguchi et al., 
2009).  
 
While the key role of E-cadherin in melanocyte biology (Gruss and Herlyn, 2001; Haass et al., 
2004; Haass et al., 2005; Kuphal and Bosserhoff, 2006, 2011) and a role for P-cadherin in 
melanoblast development and melanoma progression are recognized (Bauer and Bosserhoff, 
2006; Van Marck et al., 2005), the functions of P-cadherin in adult human physiology remain 
poorly characterized (Cavallaro and Dejana, 2011). Interestingly, in humans and mice, P-
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cadherin is prominently expressed in that part of the HF epithelium which harbors the HF 
pigmentary unit (Muller-Rover et al., 1999; Samuelov et al., 2012). Moreover, P-cadherin 
regulates HF morphogenesis in mice (Hirai et al., 1989; Shimomura et al., 2008). Most 
recently, we have shown that P-cadherin silencing inhibits hair fiber production and promotes 
HF regression (catagen induction) in human organ-cultured human HFs (Samuelov et al., 
2012). This corresponds well to the fact that mutations in the CDH3 gene, which encodes for 
the P-cadherin protein, are associated with two distinct autosomal recessive disorders: 
hypotrichosis with juvenile macular dystrophy (HJMD;OMIM 601553) and ectodermal 
dysplasia, ectrodactyly and macular dystrophy (EEM;OMIM 225280) (Shimomura et al., 
2008). These patients display sparse and short hair (Bergman et al., 2004; Shimomura et al., 
2008; Sprecher et al., 2001).  
 
Although hair pigmentation abnormalities have not been previously reported as part of the 
defining phenotype of HJMD patients, a retrospective clinical analysis of a large series of 
HJMD patients revealed that most of these patients, compared with their healthy siblings, 
display unusually fair hair, despite their dark pigmentation ethnic background (Bergman et al., 
2004; Indelman et al., 2003; Shimomura et al., 2008) (Figure 1a). Given that cadherins play a 
key role in the development of the neural crest (Pla et al., 2001; Taneyhill, 2008), from where 
melanocytes arise and travel into precisely defined epithelial compartments of mammalian 
skin and its appendages (Peters et al., 2002; Plonka et al., 2009; Tobin, 2011) we speculated 
that the hair hypopigmentation phenomenon seen in HJMD patients may reflect an important, 
hitherto unappreciated role of P-cadherin in normal human HF pigmentation. Also, P-cadherin 
knockdown had not only inhibited human hair growth, but also had reduced human HF 
pigmentation in organ culture (Samuelov et al., 2012). While this could have resulted from the 
expected catagen-associated switch-off of follicular melanogenesis (Kloepper et al., 2010; 
Slominski et al., 2005; Tobin, 2011), P-cadherin might also have exerted hair cycle-
independent effects on human melanocytes. 
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This hypothesis was probed by assessing the HF pigmentary unit (HFPU) of normal, 
melanogenically active human HFs in which P-cadherin had been knocked down in organ 
culture (Samuelov et al., 2012). These gene silencing studies in microdissected, organ-
cultured adult human scalp HFs (Kloepper et al., 2010; Philpott et al., 1990) compared 
exclusively HFs that were in the melanin-producing anagen VI stage of the hair cycle 
(Schneider et al., 2009; Tobin, 2011). These analyses were complemented by P-cadherin 
knockdown experiments in full-thickness human skin and in isolated, cultured human HF 
melanocytes.  
 
Results  
 
Follicular melanin production is reduced in patients with mutated P-cadherin 
As shown by routine histochemistry, the precortical hair matrix and the hair shafts of one 
HJMD-affected child from whom a biopsy was available, were markedly less melanized, 
compared to normally pigmented scalp HFs from healthy donors (Figure 1a-b). In addition, 
some degree of melanin incontinence into the follicular dermal papilla (DP) was visible (Figure 
1a).  
Although these findings could not be quantitatively validated (due to the unavailability of good 
longitudinal HF sections from a larger number of HJMD patients – an extremely rare pediatric 
genodermatosis), they suggested that: a) the normal level of human HF pigmentation may be 
reduced, and b) melanosome transfer into the keratinocytes of the precortical hair matrix may 
be disturbed in the absence of functional P-cadherin. 
 
P-cadherin expression in human anagen hair follicles is mostly restricted to its 
pigmentary unit 
In murine and human HFs, P-cadherin expression is most prominent in the innermost layer of 
hair matrix keratinocytes (Furukawa et al., 1997; Muller-Rover et al., 1999), i.e. in the 
epithelial HF compartment which harbors the HFPU (Tobin, 2011). Since double-
immunofluorescence of a HF melanocyte-specific marker, gp100 (Silver locus 
protein/NKI/beteb) which optimally visualizes human HFPU melanocytes (Kloepper et al., 
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2008; Singh et al., 2008; Tobin, 2011) with P-cadherin could not be successfully established, 
P-cadherin immunoreactivity (IR) was assessed on sequential hair matrix cryosections. This 
confirmed our previous findings that P-cadherin expression is most prominent in the human 
follicular hair matrix (Samuelov et al., 2012) which houses the HFPU and is in immediate 
contact with the follicular DP (Figure 1c-d). 
 
P-cadherin knockdown reduces melanin production in human anagen VI hair follicles 
P-cadherin knockdown at the mRNA and protein level can be achieved by lipofectamine-
mediated siRNA transfection of anagen VI HFs (control: scrambled oligos), which inhibits 
human hair growth and prematurely induces apoptosis-driven HF regression (catagen) 
(Samuelov et al., 2012). While routine histology already had suggested that P-cadherin 
silencing may reduce HF pigmentation (Samuelov et al., 2012), this may simply have 
reflected the normal catagen-associated switch-off pigmentation (Slominski et al., 2005). 
Therefore, this preliminary observation was systematically followed-up in the current study by 
comparing only (melanogenically fully active) anagen VI HFs between test and control 
groups. 
 
Quantitative Masson-Fontana histochemistry revealed that P-cadherin silenced anagen VI 
HFs had a significantly reduced melanin content in the HFPU region, compared to scrambled 
oligos-treated control HFs (p <0.01). A single transfection for 5-7h sufficed to obtain this effect 
(Figure 1e,f,g), and became more pronounced when HFs were transfected twice with P-
cadherin siRNA (data not shown) (as this repeated transfection caused too much HF damage, 
all subsequent experiments were performed with a single short-term transfection). The hair 
cycle stage of each hair follicle was determined by Ki-67 staining in order to demonstrate the 
proliferation activity of the HM keratinocytes below Auber's line, a marker of anagen stage 
(Kloepper et al., 2010). 
 
P-cadherin silencing reduces tyrosinase activity and expression in situ  
Since tyrosinase is the rate-limiting key enzyme of melanogenesis and drives intrafollicular, 
anagen-coupled melanin synthesis (Slominski et al., 2005; Tobin, 2011), we next investigated 
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how the reduced HF melanin content of P-cadherin-silenced anagen VI HFs correlated with 
tyrosinase activity and gene expression in situ. These analyses revealed that P-cadherin 
silencing significantly reduced both, tyrosinase activity in situ (Figure 2a-c) and tyrosinase 
mRNA steady-state level, compared to controls (Figure 2d). 
 
P-cadherin silencing reduces follicular gp100 expression 
These pigmentary effects of P-cadherin silencing were further explored by assessing the IR of 
gp100 in anagen VI HFs, since the presence of gp100 structural protein is critical for the 
production and maturation of the fibrillar structures within the melanosomes (Hoashi et al., 
2010; Kawakami et al., 2008; Singh et al., 2008; Valencia et al., 2006). Moreover, gp100 is 
further cleaved into several fragments and forms the fibrillar matrix of these organelles 
(Berson et al., 2003; Kushimoto et al., 2001; Yasumoto et al., 2004). Gp100 plays a role in the 
maturation of stage II melanosomes. Shortly after its processing in stage II melanosomes, 
gp100 is further cleaved into several fragments which form the fibrillar matrix of the organelle 
(Berson et al., 2003; Kushimoto et al., 2001; Yasumoto et al., 2004). The NKI/beteb antibody, 
which was used in the current study, recognizes cleaved gp100 when present in mature (i.e. 
stage III/VI) melanosomes (Singh et al., 2008; Yasumoto et al., 2004). 
 
Indeed, P-cadherin silenced HFs showed significantly lower gp100 IR in situ compared to 
controls. This was seen both, when measuring total IR or the number of gp100+ cells in 
defined reference areas (Figure 2e-h). Also, by confocal microscopy, the number of dendrites 
per gp100+ cells as well as their length, in P-cadherin siRNA-treated HFs were significantly 
reduced compared to controls (Figure 2i-k). This did not result from increased HF melanocyte 
apoptosis (see supplementary text S2 and Supplementary Figure S1). Moreover, the 
steady-state level of SILV mRNA, which encodes the gp100 protein (Du et al., 2003), was 
significantly reduced in P-cadherin silenced HFs, as measured by quantitative qRT-PCR 
(Figure 2l).  
Gp100 has been advocated as a marker for assessing melanosome transfer from 
melanocytes to adjacent  keratinocytes (Singh et al., 2010; Singh et al., 2008). Therefore, we 
have followed-up the above gp100 data by transmission electron microscopy (TEM) of 
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representative HF ultra-thin sections. This ultrastructural analysis showed that the HFPU of P-
cadherin silenced anagen hair bulbs contained HF melanocytes that had accumulated an 
excessive amount of melanosomes; instead, only a very low number of melanosomes was 
seen to have been successfully transferred to adjacent hair matrix keratinocyets 
(Supplementary Figure S2). Apart from this phenomenon, however, the ultrastructural 
appearance and amount of melanocytes and melanosomes in test and control HFs were 
normal. This ultrastructural evidence raises the possibility that P-cadherin expression might 
be involved in orderly melanosome transfer within the human HFPU. However, this 
hypothesis would have to be further explored by formal melanosome tracking assays, which 
were outside of the scope of the current study. 
 
P-cadherin appears dispensable for human epidermal melanogenesis 
P-cadherin expression is also found in human epidermis, where it reportedly is expressed 
only in the basal layer, while E-cadherin is expressed throughout the epidermis (Fujita et al., 
1992; Furukawa et al., 1997; Hirai et al., 1989; Magerl et al., 2001; Muller-Rover et al., 1999). 
Recently, however, we found, that intraepidermal P-cadherin IR in human epidermis is more 
widespread than previously reported and actually predominates in the stratum spinosum and 
stratum granulosum of the epidermis (Samuelov et al., 2012). In some individuals, P-cadherin 
IR was even reduced in the basal layer of human epidermis (Samuelov et al., 2012) and thus 
does not correlate with the preferential basal/suprabasal location of epidermal melanocytes in 
human skin. Therefore, we next assessed whether P-cadherin expression is also required for 
normal human epidermis  by P-cadherin knockdown in full-thickness adult human skin organ 
culture (Samuelov et al., 2012).  
 
Comparing P-cadherin siRNA- or scrambled oligo-transfected human skin punches (2 mm), 
no significant quantitative difference in terms of melanin content, gp100 IR and tyrosinase 
activity was seen between test and control samples (Supplementary Figure S3). Therefore, in 
human skin, the topobiological dependence of melanogenesis on adequate P-cadherin 
expression is melanocyte subpopulation-specific and appears to be restricted to melanocytes 
residing in that epithelial skin compartment where P-cadherin expression is most prominent 
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and where E-cadherin is reduced or even absent (Muller-Rover et al., 1999): the innermost 
hair matrix. 
 
P-cadherin silencing inhibits melanogenesis, tyrosinase activity and microphthalmia-
associated transcription factor expression in isolated human hair follicle melanocytes 
Since P-cadherin is expressed on both melanocytes and keratinocytes in the HFPU, we 
wanted to clarify whether the reduced pigmentation after P-cadherin silencing depends on 
melanocyte-keratinocyte interactions within the HFPU or whether P-cadherin silencing also 
inhibits melanogenesis in the absence of keratinocytes, i.e. in isolated, cultured human HF 
melanocytes (HFMs) in vitro. After having confirmed successful P-cadherin knockdown in 
isolated, cultured HFMs by P-cadherin immunostaining (Figure 3a-c) we found that P-
cadherin silenced HFMs have a reduced melanin content and tyrosinase activity compared to 
controls (Figure 3d-k). MITF expression, strongly cytoplasmic and slightly intranuclear, was  
downregulated in isolated HFMs in vitro by P-cadherin knockdown (Figure 3l-n). No significant 
difference was found in gp100 expression between P-cadherin vs. scrambled-oligos-treated 
HFMs (data not shown). This suggests that the P-cadherin-dependence of normal 
intrafollicular melanogenesis reflects a direct P-cadherin effect on HF melanocytes. 
 
MITF, SCF, and c-Kit expression are down regulated by P-cadherin silencing  
As a first attempt at elucidating molecular mechanisms that may underlie the observed P-
cadherin dependence of human HF pigmentation, the expression of the transcription factor, 
microphthalmia-associated transcription factor (MITF), widely acclaimed as the “master  
regulator” of pigmentation (McGill et al., 2006; Nishimura et al., 2005; Vachtenheim and 
Borovansky, 2010) was examined. Likewise, we assessed the levels of stem cell factor 
(SCF), a key growth factor that controls melanocyte survival and anagen-dependent 
melanogenesis in the HF (Botchkareva et al., 2001; Slominski et al., 2005; Tobin, 2011) and 
its high affinity receptor, c-Kit, in the innermost hair matrix.  
 
This showed a significant downregulation of SCF, both at the protein and gene level by P-
cadherin silencing (Figure 4a-d). Moreover, c-Kit IR was also reduced (Figure 4e-g). In 
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addition, the number of MITF+ cells around the DP (Figure 4h-j) and MITF steady-state 
transcript levels (Figure 4k) were significantly reduced in mRNA extracts from P-cadherin 
siRNA-treated HFs compared to scrambled oligos-treated anagen VI hair bulbs. 
Asmentioned, MITF was also strongly downregulated in isolated HFMs in vitro following P-
cadherin silencing (Figure 3l-n). This suggests that the greatly reduced melanogenesis and 
disturbed melanosome transfer within the HFPU after P-cadherin silencing may result from a 
decline in MITF/SCF/c-Kit-mediated signaling. 
 
MITF down-regulation may result from inhibition of the canonical Wnt signaling by P-
cadherin silencing  
Previously, we had shown that the hair growth-inhibitory effects of P-cadherin silencing are 
associated with an inhibition of canonical Wnt signaling (Samuelov et al., 2012). Since MITF 
also is a well-known target gene of β-catenin/Wnt signaling (Bellei et al., 2010; Takeda et al., 
2000), we hypothesized that the inhibition of melanogenesis by P-cadherin silencing may also 
result from changes in the cytoplasmic pool and stabilization of β-catenin, thus reducing the 
expression of β-catenin target genes. In fact, β-catenin IR was significantly down-regulated in 
the innermost hair matrix of P-cadherin silenced HFs. Instead, no significant differences in β-
catenin IR were found in the outer root sheath (ORS), where P-cadherin is co-expressed with 
E-cadherin (Muller-Rover et al., 1999) (Figure 5a-c). In contrast, phospho-β-catenin and 
glycogen synthase kinase 3 beta (GSK3β) were significantly increased in P-cadherin silenced 
HFs (Figure 5d-i). Therefore, the reduced MITF expression may result from intramelanocytic 
Wnt inhibition, followed by MITF down regulation, and ultimately by reduction of tyrosinase 
activity, gp100 expression and melanin synthesis.  
 
To further correlate the reduced MITF expression with Wnt signaling inhibition, we cultured P-
cadherin-silenced HFs with the potent, non-specific GSK3β inhibitor, lithium chloride (LiCl). 
As we had reported before, this completely reversed the effect of P-cadherin silencing on the 
transcription of the key β-catenin target gene, axin2 (Samuelov et al., 2012). Interestingly, the 
MITF mRNA steady state-level was not reversed (and was even further downregulated) by 
LiCl-mediated GSK3β inhibition (Figure 5j), while phospho-β-catenin IR in anagen VI HFs was 
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normalized by LiCl in P-cadherin silenced HFs (Supplementary Figure S4). 
Proopiomelanocortin (POMC) transcription and alpha-melanocyte stimulating hormone (α-
MSH) and adrenocorticotropic hormone (ACTH) protein IR in situ were essentially unchanged 
(Supplementary Figure S5). These observations suggest that P-cadherin knockdown inhibits 
HF pigmentation primarily through the GSK3β/Wnt pathway, while POMC, α-MSH, and ACTH 
(i.e. key neuroendocrine controls of human HF pigmentation (Paus, 2011; Slominski et al., 
2005)) appear to be unaffected. 
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Discussion 
 
Here, we provide the first evidence that a member of the cadherin family, P-cadherin, is 
important for the control of normal human hair pigmentation in situ. Using the HF as a 
physiologically and clinically relevant model system for testing normal adult human 
melanocyte functions within their natural tissue context (Paus, 2011; Tobin, 2011), we show 
that P-cadherin plays an essential regulatory role in the control of human HF melanogenesis. 
In contrast, human epidermal pigmentation in situ is independent of P-cadherin-mediated 
signaling. Such a strikingly differential dependence of melanocytes within the same organ 
(here: human skin) on one member of the cadherin family has not previously been reported. 
Thus, P-cadherin provides a crucial topobiological cue for HF melanocytes, as opposed to 
their epidermal counterparts. It deserves to be explored whether P-cadherin also is important 
in human retinal pigment epithelium (see supplementary text S3). 
While P-cadherin has not previously been implicated in the biology of adult, differentiated 
human melanocytes in vitro or in vivo, the hair pigmentation phenotype of HJMD patients had 
encouraged the hypothesis that P-cadherin may control human HF melanocyte functions. Our 
findings verify this hypothesis, and raise the question how P-cadherin exerts its effects on 
mature human HF melanocytes in situ and in vitro.  
Since classical melanogenesis-promoting neurohormones, which are prominently produced 
within the human HF epithelium (Paus, 2011; Slominski et al., 2005; Tobin, 2011) appears to 
be unaffected by P-cadherin silencing, the Wnt pathway offers one reasonable candidate 
mechanism. Wnt signaling has already been implicated in the human hair growth-modulatory 
effects of P-cadherin (Samuelov et al., 2012) and is up-stream of MITF (Bellei et al., 2010; 
Takeda et al., 2000). MITF controls the production of key melanogenic enzymes  (Aksan and 
Goding, 1998; Bellei et al., 2010; Bertolotto et al., 1998a; Bertolotto et al., 1998b; Yasumoto 
et al., 1994) and melanosomal matrix proteins such as gp100 (Du et al., 2003). Moreover, 
Wnt signaling is essential for neural crest and melanocyte development, and mice lacking 
Wnt1 and Wnt3a, which trigger the canonical pathway resulting in β-catenin target gene 
expression, suffer from pigmentary defects (Ikeya et al., 1997). In contrast, inhibition of 
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canonical Wnt signaling downregulates melanocyte density and differentiation via reducing 
MITF expression (Yamaguchi et al., 2007). Wnt/β-catenin signaling furthermore upregulates 
MITF (Bellei et al., 2010; Takeda et al., 2000) . Moreover, β-catenin functionally interacts with 
the MITF protein and then activates MITF-specific target genes (Schepsky et al., 2006) (see 
supplementary Figure S6a).  
 
Therefore, our data raise the possibility that P-cadherin knockdown reduces expression of 
MITF, the "master regulator" of melanogenesis (Vachtenheim and Borovansky, 2010),  
through increased β-catenin degradation and downregulation of cytoplasmic β-catenin 
available for Wnt signaling. As a consequence, melanogenesis, tyrosinase activity, gp100 
production and melanosome transfer to keratinocytes are all inhibited (see hypothetical 
scenario summarized in Supplementary Figure S6b). Interestingly, non-specific GSK3β 
inhibition by LiCl upregulated transcription of the prototypic β-catenin target gene, Axin2 
(Samuelov et al., 2012), while the mRNA level of MITF remained low. This suggests that, 
besides the canonical Wnt signaling pathway, other GSK3β-related mechanisms may also 
contribute to regulating MITF at the mRNA level, e.g. SCF/c-Kit-mediated signaling (for 
discussion, see supplementary text S4) and LiCl treatment did not suffice to reverse the effect 
of P-cadherin silencing on MITF expression. 
 
Since the control of MITF expression is rather complex and is also regulated by other 
signaling pathways besides GSK3β/Wnt (e.g. MAPK and CREB phosphorylation through 
SCF) (Nakajima et al., 2012), this may explain the absence of MITF mRNA upregulation after 
inhibiting GSK3β. In contrast, the transcript levels of Axin2, a specific  β-catenin target gene 
(Lovatt and Bijlmakers, 2010), are restored after culturing P-cadherin-silenced HFs in the 
presence of a GSK3β inhibitor (Samuelov et al., 2012). Attenuated MITF- and/or SCF/c-Kit 
signaling may also underlie the reduced HF melanocyte dendricity observed upon P-cadherin 
silencing (for discussion, see supplementary text S5). 
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The melanocyte subpopulation-specific control of human pigmentation by a cadherin family 
member identified here not only opens a new frontier in general pigment and cell adhesion 
biology, but is also clinically relevant: it suggests novel strategies for the therapeutic 
modulation of human HF pigmentation (including hair graying) via targeting P-cadherin-
mediated signaling. Our data also underscore that P-cadherin silencing in human HFs 
provides an intriguing preclinical research model for dissecting the as yet incompletely 
understood pathobiological consequences of loss of function-mutations of the CDH3 gene in 
HJMD and EEM syndromes for human tissue pathology.  
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Materials and Methods 
 
Tissue collection, organ culture, and P-cadherin knockdown 
The same human anagen VI HFs from five patients undergoing routine face-lift surgery whose 
growth response to P-cadherin silencing we had previously examined (after ethics approval 
and informed patient consent) (Samuelov et al., 2012) were re-analyzed in the current study 
for pigmentary phenomena. Since the current study constitutes a systematic re-analysis of the 
same human HF and skin samples reported before in Samuelov et al. (2012), see this study 
for details on tissue collection, organ culture, and P-cadherin knockdown. In the current study, 
only anagen VI (melanogenically active) HFs were included in all the experiments. 
 
Hair follicle melanocyte culture  
HFMs cultures were established as described (Kauser et al., 2005) (for details, see 
supplementary data). 
 
Melanin histochemistry 
Quantitative melanin histochemistry by Masson–Fontana stain was performed as described 
(Gaspar et al., 2010) (for details see supplementary data).  
 
Immunohistochemistry (LSAB – Peroxidase)  
P-cadherin, β -catenin and phospho- β -catenin IR was detected by LSAB-peroxidase 
immunohistochemistry as described in the supplementary data and (Samuelov et al., 2012). 
 
Immunofluorescence microscopy and quantitative immunohistomorphometry  
Immunfluorescence stainings for β –catenin, phospho- β –catenin and GSK3β were 
performed as described before (Samuelov et al., 2012). 
Immunfluorescence microscopy for SCF, gp100, c-Kit, MITF, ACTH, α-MSH and quantitative 
immunohistomorphometry are described in the supplementary data.  
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Tyrosinase activity and melanocyte apoptosis in situ  
The tyramide-based tyrosinase assay was used for measuring tyrosinase activity in situ as 
previously described (Han et al., 2002; Kloepper et al., 2010), while HF melanocyte apoptosis 
was examined by gp100/TUNEL double-immunofluorescence (see supplementary data). 
 
Histology  
Archival scalp skin sections of one 5 year old female HJMD patient were stained with 
hematoxylin and eosin (Samuelov et al., 2012). Scalp skin biopsy had been obtained for 
diagnostic purposes after informed consent.  
 
Quantitative Real-Time PCR (qRT-PCR) 
qRT-PCR was performed on an ABI Prism 7000 sequence detection system (Applied 
Biosystems/Life Technologies, Foster City, CA, USA) using the 5’ nuclease assay as 
described before (Bodo et al., 2005; Dobrosi et al., 2008; Toth et al., 2009) (for primers and 
details, see supplementary data and (Samuelov et al., 2012). 
 
Confocal microscopy and transmission electron microscopy  
Confocal microscopy and transmission electron microscopy were performed as described 
(Samuelov et al., 2012).  
 
For methodological details, see supplementary information. 
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Figure legends  
 
Figure 1. Follicular melanin production is reduced in patients with HJMD, P-cadherin 
expression in normal human anagen VI hair follicles overlaps the hair follicle 
pigmentary unit and reduces melanin content in P-cadherin silenced anagen VI hair 
follicles 
(a) Scalp skin biopsy obtained from HJMD patient. Hematoxylin Eosin (H&E) staining 
demonstrates a vellus hair follicle (HF) with no evidence of melanin content in the hair shaft 
(HS) and precortical hair matrix (HM) (magnification x400). The arrowhead points to melanin 
granules in the dermal papilla, indicating melanin incontinence.  
(b) H&E staining of normally pigmented scalp HF of healthy human individual. The 
arrowheads indicate melanin in the HM and the HS.  
(c,d) The pictures represent sequential sections of the same normal anagen VI HF. (c) 
Positive NKIbeteb (gp100) immunoeactivity (IR) in an anagen VI HF. (d) Positive P-cadherin 
IR in the innermost cell layer of matrix keratinocytes. Dotted lines represent the area of P-
cadherin (d) and NKIbeteb (c) expression. Note the overlap expression of P-cadherin with the 
HF pigmentary unit. Since the P-cadherin antibody works only with highly sensitive 
immunohistochemistry method, double staining of NKIbeteb and P-cadherin could not be 
applied. 
(e) The graph represents histomorphometic analysis of Masson-Fontana staining, which 
revealed significant downregulation of melanin content in P-cadherin siRNA-treated HFs 
compared to scrambled oligos-treated ones. Similar results were obtained after two 
transfections with P-cadherin siRNA vs. scrambled oligos (data not shown). Data was pooled 
from two highly comparable experiments. **p<0.01, n=12, Mann Whitney test. 
(f,g) Note the reduced melanin content in P-cadherin siRNA-treated anagen VI HFs compared 
to scrambled oligos-treated HFs. Each Masson-Fontana staining picture is accompanied by 
the corresponding Ki-67 staining of the same HF in order to demonstrate the proliferation 
activity of the HM keratinocytes below Auber's line, a marker of anagen stage (Kloepper et al., 
2010). The dotted lines represent Auber's line.  
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DP – dermal papilla; HF – hair follicle; HJMD - hypotrichosis with juvenile macular dystrophy; 
HM – hair matrix; HS – hair shaft; IHM – innermost hair matrix; IR – immunoreactivity; ORS – 
outer root sheath; PCHM – precortical hair matrix sheath; RD – reticular dermis; SC – 
subcutaneous fat. 
 
Figure 2. P-cadherin knockdown downregulates tyrosinase activity and gp100 at the 
mRNA and protein level  
(a-c) Reduced tyrosinase activity In anagen VI P-cadherin siRNA-treated hair follicles (HFs), 
(b) compared to scrambled oligos-treated HFs (a). Dotted lines represent reference areas of 
measurements. Data was pooled from two highly comparable experiments in which HFs were 
transfected once with P-cadherin siRNA vs. scrambled oligos. The same results were 
achieved when HFs were transfected twice during the four day culture. **p<0.01, Mann 
Whitney test, n=10-13. 
(d) mRNA level of TYR in P-cadherin siRNA vs. scrambled oligos treated HFs. ***p<0.001, 
Student’s t test for unpaired samples.  
(e-f) Reduced gp100 immunoreactivity (IR) and number of gp100+ cells in P-cadherin siRNA-
treated hair follicles (HFs) (f) compared to scrambled oligos-treated ones (e). White dotted 
lines represent reference areas of measurement. Yellow dotted lines represent the basement 
membrane. 
(g) Histomorphometric analysis of gp100 IR. Data was pooled from two highly comparable 
experiments. *p<0.05, Mann Whitney test, n=13-16. 
(h) Reduced gp100+ cells in the P-cadherin siRNA-treated HFs. Data was pooled from two 
highly comparable experiments. *p<0.05, Mann Whitney test, n=13-16. 
(i-k) Reduced number of dendrites per gp100+ cell in P-cadherin siRNA-treated HFs (j) 
compared to scrambled oligos-treated ones (i), as was measured by confocal microscopy. 
Yellow dotted lines represent the basement membrane. Note the fewer and shorter dendrites 
in the P-cadherin silenced HFs compared to control (yellow arrow heads). Data was pooled 
from two highly comparable experiments. **p<0.01, Mann Whitney test, n=96-119. 
(l) Reduced gp100 transcript level in the P-cadherin siRNA-treated HFs. ***p<0.001, 
Student’s t test for unpaired samples.  
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In all mRNA results (d, l) transcript levels were compared to glyceraldehyde 3-phosphate 
dehydrogenase, peptidylprolyl isomerase A or β-actin.  
DP – dermal papilla; HS – hair shaft; IHM – innermost hair matrix; IR – immunoreactivity. 
 
Figure 3. P-cadherin knockdown reduces melanogenesis, tyrosinase activity and MITF 
in isolated follicular melanocytes 
(a-c) Reduced P-cadherin expression in hair follicle melanocytes (HFMs) treated with P-
cadherin siRNA (b) compared to HFMs treated with scrambled oligos (a). C represents 
negative control with retrieving the primary antibody. 
(d-g) Reduced melanin content by Masson-Fontana staining in P-cadherin silenced HFMs (e) 
compared to HFMs treated with scrambled-oligos (d). F represents negative control without 
silver nitrate. 
(h-k) P-cadherin silenced HFMs (i) demonstrate reduced tyrosinase activity compared to 
scrambled oligos-treated HFMs (h). Tyrosinase expression was also significantly reduced in 
the P-cadherin silenced HFMs (data not shown). 
(l-n) Reduced microphthalmia-associated transcription factor expression in HFMs treated with 
P-cadherin siRNA compared to scrambled oligos-treated HFMs. N represents negative 
control with retrieving the primary antibody. 
MITF - microphthalmia-associated transcription factor; P-cad. – P-cadherin; Scr. – scrambled. 
 
Figure 4. P-cadherin knockdown significantly downregulates stem cell factor, c-Kit and 
microphthalmia-associated transcription factor significantly  
(a-c) Reduced stem cell factor (SCF) expression in P-cadherin silenced HFs (b) compared to 
control (a). Data was pooled from two highly comparable experiments in which HFs were 
transfected once with P-cadherin siRNA vs. scrambled oligos. Dotted lines represent 
reference areas of measurements. White lines encircle the dermal papilla (DP).  *** p<0.0001, 
Mann Whitney test, n=15-17. 
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(d) mRNA level of SCF in P-cadherin siRNA vs. scrambled oligos treated HFs. **p<0.01, 
Student’s t test for unpaired samples.  
(e-g) Reduced c-Kit expression in P-cadherin silenced HFs (f) compared to control (e).Data 
was pooled from two highly comparable experiments in which HFs were transfected once with 
P-cadherin siRNA vs. scrambled oligos. Dotted lines represent reference areas of 
measurements.  ** p<0.01, Mann Whitney test, n=11-14. 
(h-j) Reduced number of microphthalmia-associated transcription factor (MITF) positive cells 
around the DP of P-cadherin silenced HFs (i) compared to control (h). Data was pooled from 
two highly comparable experiments in which HFs were transfected once with P-cadherin 
siRNA vs. scrambled oligos. Arrow represents MITF+ cells around the DP.  **p<0.01, Mann 
Whitney test, n=11-16. 
(k) mRNA level of MITF. **p<0.01, Student’s t test for unpaired samples.  
In all mRNA results (d, k) transcript levels were compared to glyceraldehyde 3-phosphate 
dehydrogenase, peptidylprolyl isomerase A or β-actin.  
DP – dermal papilla; HS – hair shaft; IHM – innermost hair matrix; IR – immunoreactivity; 
MITF - microphthalmia-associated transcription factor; SCF – stem cell factor; TYR – 
tyrosinase. 
Figure 5. P-cadherin silencing in anagen hair follicles increases degradation of β-
catenin and reduces the expression of microphthalmia-associated transcription factor 
(a-c) Reduced β-catenin immunoreactivity (IR) in anagen hair follicles (HFs) after P-cadherin 
siRNA treatment, specifically in the innermost hair matrix (IHM). No significant difference was 
found in the outer root sheath. Data was pooled from two highly comparable experiments. 
***p<0.0001, Mann Whitney test, n=14-22. 
(d-f) Upregulation of glycogen synthase kinase 3 beta (GSK3β) IR in the innermost cell layer 
of matrix keratinocytes after P-cadherin siRNA treatment. Data was pooled from two highly 
comparable experiments. **p<0.01, Mann Whitney test, n=9-15. 
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(g-i) Increased phospho-β-catenin IR in anagen HFs after P-cadherin siRNA treatment, 
specifically in the IHM. Data was pooled from two highly comparable experiments. **p<0.01, 
Mann Whitney test, n=14-16. 
(j) Microphthalmia-associated transcription factor (MITF) mRNA level is significantly 
downregulated in P-cadherin silenced HFs. Culturing P-cadherin silenced HFs with the potent 
GSK3β inhibitor, lithium chloride (LiCl), did not reverse the effect of P-cadherin silencing in 
terms of MITF transcript level, although MITF is a known target gene of β-catenin. *p<0.05; 
***p<0.001, Student’s t test for unpaired samples. The transcript levels were compared to 
glyceraldehyde 3-phosphate dehydrogenase, peptidylprolyl isomerase A or β-actin.  
DP – dermal papilla; GSK3β - Glycogen synthase kinase 3 beta; HF – hair follicle; IHM – 
innermost hair matrix; IR – immunoreactivity; LiCl - lithium chloride; MITF - microphthalmia-
associated transcription factor; ORS – outer root sheath; P-cad. – P-cadherin; P- β-catenin – 
phospho-β-catenin; Scr. – scrambled. 
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         Supplementary data 
 
Supplementary Text S1 
Signaling by the Wnt pathway is triggered by the binding of secreted Wnt growth 
factor proteins to the Frizzled receptor. In the absence of Wnt ligands, cytoplasmic β-
catenin is recruited into a complex that contains adenomatous polyposis coli and 
axins, and is amino-terminally phosphorylated by axin-bound casein kinase 1a and 
glycogen synthase kinase 3β (GSK3β) at Ser33/37/Thr41. Following phosphorylation, 
β-catenin is targeted for proteasome-dependent degradation. In the presence of Wnt 
ligands, the GSK3β-dependent phosphorylation of β-catenin is blocked, resulting in β-
catenin stabilization and nuclear translocation, where it can heterodimerize with T-cell 
factor and Lymphoid enhancer-binding factor-1 transcription factors, leading to the 
activation of specific β-catenin target genes, such as Axin2 (Bienz, 2005; Heuberger 
and Birchmeier, 2010; Klaus and Birchmeier, 2008; Liu et al., 2002; Tauriello and 
Maurice, 2010). 
 
Supplementary Text S2 
In order to check whether the observed reduction in the number of microscopically 
visible dendrites per gp100+ cell resulted from increased HF melanocyte apoptosis, 
gp100/TUNEL double-immunofluorescence was established. This also served as an 
independent confirmation that only anagen VI HFs were compared with each other, 
as catagen development is associated with HF melanocyte apoptosis (Sharov et al., 
2005; Tobin et al., 1998). By gp100/TUNEL double-immunofluorescence no 
significant differences in HF melanocyte apoptosis between test and control anagen 
hair bulbs were observed (Supplementary Figure 1). 
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Supplementary Text S3  
We show here that P-cadherin appears dispensable for pigmentation in normal 
human epidermis and thus seems to be of selective importance in the HFPU, where 
E-cadherin expression is low or absent, while P-cadherin is prominently expressed. 
However, P-cadherin expression was demonstrated in retinal pigment epithelium 
(RPE) cells of the developing mouse retina (Xu et al., 2002) and also in adult human 
RPE, where it is co-expressed with E-cadherin (Burke et al., 1999). Interestingly, 
diffuse pigmentary abnormalities confined to the macula and surrounding areas are 
an early and characteristic ophthalmologic features of HJMD patients (Leibu et al., 
2006). Therefore, it deserves to be explored in future studies whether P-cadherin is 
not only essential in the HFPU, but also in the RPE. 
 
Supplementary Text S4 
Normal skin keratinocytes, including those of the hair matrix, constitutively produce 
SCF (Longley et al., 1993; Peters et al., 2003). Its cognate receptor, c-Kit, is 
expressed on various cell types including HF melanocytes (Broudy, 1997) and hair 
matrix keratinocytes (Peters et al., 2003). SCF/c-Kit-mediated signaling plays a key 
role in the control of hair pigmentation (Botchkarev et al., 1999; Hachiya et al., 2009; 
Jackson, 1997; Nishikawa et al., 1991; Slominski et al., 1998), melanoblast and/or 
melanocyte migration, melanocyte survival, proliferation and differentiation as well as 
the maintenance of postnatal cutaneous melanogenesis (Besmer et al., 1993; 
Botchkareva et al., 2001; Grichnik et al., 1998; Hachiya et al., 2009; Nishikawa et al., 
1991; Steel et al., 1992; Williams et al., 1992). Indeed, c-Kit and MITF expression are 
significantly lower in unpigmented than in pigmented human HFs, and, administration 
of a neutralizing anti-Kit antibody abolishes MITF and tyrosinase expression, resulting 
in depigmentation of human HFs (Hachiya et al., 2009). Moreover, melanoblasts that 
form the P-cadherin positive HFPU during murine HF development retain c-Kit 
expression during their differentiation into melanin-producing HFPU melanocytes, 
whereas amelanotic melanocytes residing in the ORS lose their c-Kit expression 
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(Peters et al., 2002). SCF signaling triggers the phosphorylation of MITF (Hemesath 
et al., 1998; Wu et al., 2000) and is associated with an increased production of MITF 
protein via the phosphorylation of cAMP responsive element binding protein (CREB), 
due to the activation of RSK by mitogen-activated protein kinase (MAPK) pathway in 
human melanocytes (Sato-Jin et al., 2008). Furthermore, SCF stimulates the 
expression and function of c-Kit (Imokawa et al., 1996).  
On this background, the reduced expression of c-Kit observed in P-cadherin-silenced 
human HFs may well result from a markedly diminished expression of SCF in the 
adjacent, P-cadherin-positive inner hair matrix keratinocytes. Mechanistically, P-
cadherin silencing in both, the innermost hair matrix keratinocytes and in HFPU 
melanocytes likely results in reduced intracellular β-catenin levels and a subsequent 
downregulation of β-catenin target genes, including MITF, in both cell populations. 
This downregulation of canonical Wnt signaling probably causes reductions in both, 
SCF expression and secretion by hair matrix keratinocytes and c-Kit expression on 
the adjacent HFPU melanocytes. Reduced c-Kit signaling in HFPU melanocytes then 
may further downregulate MITF expression, tyrosinase activity, gp100 expression, 
and melanosome transfer, thus leading to greatly reduced intrafollicular 
melanogenesis (Supplementary Figure S5b). 
Our results demonstrated that nuclear expression levels of MITF-M appear relatively 
similar in P-cadherin siRNA treated HFMs and the control in this study. However, 
there is evidence that MITF-M expression level in the cytoplasm is reduced after P-
cadherin siRNA treatment. As MITF-M is initially synthesized in the cytoplasm, it must 
thereafter be translocated to the nucleus in order to function as a transcription factor 
for several melanocyte-specific genes. Therefore, the relative availability of MITF-M in 
the melanocyte (i.e., expression levels in cytoplasmic and subsequent nuclear 
translocation kinetics) is likely to influence the subsequent activation of the 
melanogenic program in melanocytes.  For example, GSK3 inhibition in melanocytes 
promotes nuclear translocation of MITF (Bellei et al., 2008). The activation of the 
melanogenic program by GSK3 inhibition not only stimulates MITF expression, but 
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also promotes its translocation from the cytoplasm to the nuclear compartment. Thus, 
MITF activity may be regulated by its cellular localization, and that our short-term 
pulse reduction of MITF-M via P-cadherin siRNA  treatment may reduce overall MITF-
M associated gene transcriptional activity in HFMs. 
  
Supplementary Text S5  
Visible hair pigmentation requires the transfer of melanin granules from differentiated 
melanocytes of the HFPU to keratinocytes of the precortical hair matrix (Slominski et 
al., 2005; Tobin, 2011). For effective transfer, melanosomes must accumulate at the 
distal end of the melanocyte dendrites, requiring microtubule-dependent melanosome 
transfer along the dendrites before coupling to myosin Va within the actin-rich regions 
of the dendrites (Belleudi et al., 2011; Singh et al., 2010; Wu et al., 1998). The 
cadherins are indirectly linked to microtubules and/or filamentous actin (via adherens 
junctions) by β- and α- catenin. In addition, the adherens junctions play a role in 
microtubule and actin organization within the cell (Harris and Tepass, 2010). 
Therefore, our ultrastructural results are in line with the hypothesis that P-cadherin 
silencing in human HFMs may result in actin and microtubule abnormalities which 
may block orderly melanosome transfer to adjacent keratinocytes.  
P-cadherin silencing also greatly reduced the number and length of dendrites 
generated by human HFPU melanocytes in situ, as shown by confocal microscopy  
(Figure 2i-k), possibly as a result of attenuated MITF (Figure 4h-k) and SCF/c-Kit 
(Figure 4a-g) expression. This may also be a cause for disruption and reduction of 
melanosome transfer (Supplementary Figure S2). Melanosome transfer to 
keratinocytes results, at least in part, from the direct delivery of melanosomes into 
keratinocytes via filopodia (Scott et al., 2002; Singh et al., 2010; Singh et al., 2008). 
Tubular filopodia are composed of and form actin filaments, by physical contact and 
fusion with the target cell, a direct cytoplasmic bridge which allows organelle transfer. 
In melanocytes, the filopodia extend from the dendrite tips and adhere to the surface 
of adjacent keratinocytes in order to facilitate melanosome transfer into the 
Page 36 of 91Journal of Investigative Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
5 
 
keratinocyte cytoplasm (Scott et al., 2002; Singh et al., 2010; Singh et al., 2008). This 
mechanism of melanosome transfer may be impaired by P-cadherin function, 
secondary to abnormalities of the adherens junctions and the melanocyte 
cytoskeleton induced by P-cadherin silencing or spontaneous function-impairing 
mutations. In conclusion, our data, including reduced expression of gp100 (a marker 
antigen for studying melanosome transfer) and ultrastructural evidence that hair 
matrix keratinocytes in P-cadherin-silenced HFs exhibit accumulation of an excessive 
amount of melanosomes, raise the possibility that P-cadherin expression might be 
directly involved in orderly melanosome transfer within the human HFPU. However, 
this hypothesis would have to be further explored by formal melanosome tracking 
assays, which were outside of the scope of the current study 
 
Supplementary Materials and Methods 
 
Tissue collection 
The same human anagen VI hair follicles (HFs) from five patients undergoing routine 
face-lift surgery whose growth response to P-cadherin silencing we had previously 
examined (Samuelov et al., 2012) were re-analyzed in the current study for 
pigmentary phenomena [after ethics approval and informed patient consent, as 
described before (Samuelov et al., 2012)]. Five independent HF organ culture 
experiments in serum-free medium were performed using the previously described 
protocol (Bodo et al., 2005; Philpott et al., 1990; Sanders et al., 1994), with 60-132 
HFs per culture. This was complemented with two full-thickness human skin organ 
cultures (Bodo et al., 2010; Lu et al., 2007) from two different patients, also under 
serum-free conditions.  
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Hair follicle and skin organ culture  
Per experiment, HFs were divided into equal numbers for the two different treatments 
of P-cadherin siRNA and scrambled oligos groups. In order to explore the effect of 
GSK3β inhibition on HF pigmentation, in one culture, the culture medium was 
supplemented with the potent GSK3β inhibitor lithium chloride (LiCl) (Tighe et al., 
2007) in the concentration of 40mM (Sigma, Munich, Germany). LiCl was added only 
once to the culture medium (either as the only treatment or 5-7 hours (hrs) after 
transfection) and HFs were embedded in Shandon Cryomatrix (Pittsburgh, PA, USA) 
and snaped frozen in liquid nitrogen 24hrs afterwards.  
Hair shaft length was measured daily using an inverted binocular microscope 
(Kloepper et al., 2008; Philpott et al., 1990) and culture medium was replaced after 
the transfection and then every other day. On days 2 and 4 (and also on day 3 in the 
culture where two transfections were performed), samples of culture medium were 
taken for lactate dehydrogenase (LDH) level measuring as a general cell toxicity 
parameter in human skin organ culture (Lu et al., 2007). This showed no significant 
increase in the LDH release of P-cadherin-silenced HFs compared to scrambled 
oligo-controls after a single transfection, while a rise in LDH levels after repeated 
siRNA treatment was demonstrated (data not shown). This indicates minimal toxicity 
after a single transfection, while repeated transfection carries the expected risk of 
increased toxicity. Twenty-four hours after the transfection (on day 1 in the single 
transfection cultures and on day 4 in the double transfection culture), 12-15 HFs were 
frozen in liquid nitrogen for RNA extraction and mRNA analysis. The rest of the HFs 
were embedded in Shandon Cryomatrix (Pittsburgh, PA, USA) and snap frozen in 
liquid nitrogen on day 4 of culture. HFs that were treated with LiCl, were embedded 
24h after the beginning of treatment. 
6 µm thick cryosections of HFs were cut for immunohistological staining, and were 
stored at -80
ο
C until use. The efficacy of gene silencing was confirmed by P-cadherin 
specific immunohistochemistry (Samuelov et al., 2012) and qRT-PCR (data not 
shown). 
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In the two skin organ cultures, 2 mm full-thickness skin punches were transfected 
with P-cadherin siRNA and control siRNA at day 0 (6 skin punches per group) using 
exactly same serum-free organ culture protocol as in the HF cultures. In one culture, 
24h after the transfection, skin punches were frozen in liquid nitrogen for RNA 
extraction and CDH3 mRNA analysis. In the second culture, skin punches were 
embedded in Shandon Cryomatrix (Pittsburgh, PA, USA) and snap frozen in liquid 
nitrogen on day 4 of culture. 7 µm thick cryosections of skin punches were cut for 
immunohistochemistry. The efficacy of gene silencing was confirmed by P-cadherin 
specific immunohistochemistry and qRT-PCR (data not shown).  
 
P-cadherin knockdown  
P-cadherin knockdown was performed as previously described (Samuelov et al., 
2012). In four HF organ culture experiments (each from a different patient), HFs were 
transfected with human P-cadherin siRNA (Sigma-Aldrich, Munich, Germany, 
SASI_Hs02_00332561, 5'- CCAAUAUCUGUCCCUGAAA-3') at day 0 for 5-7 hrs. 
In one additional HF organ culture, HFs were transfected twice – i.e. at days 0 and 3 
of culture. Transfection with scrambled oligonucleotides (Santa Cruz, CA, USA, sc-
37007) served as control. After transfection HFs were maintained in a 24-well plate 
with 500 µl Williams medium E (Biochrom, Cambridge, UK) supplemented with 1% L-
glutamine (Invitrogen, Paisley, UK), 0.02% hydrocortisone (Sigma-Aldrich, Munich, 
Germany), 0.1% insulin (Sigma-Aldrich) and 1% antibiotic⁄antimycotic mixture (Gibco, 
Karlsruhe, Germany). All reagents required for transfection, except P-cadherin 
specific siRNA and control siRNA, were obtained from Santa Cruz Biotechnology Inc 
(siRNA transfection reagent, sc-29528; siRNA transfection medium, sc-36868). HF 
transfection was performed according to the manufacturer’s protocol (Santa Cruz 
Biotechnology Inc, CA, USA) (Samuelov et al., 2012). 
In order to ensure no off-targets activation by the P-cadherin siRNA, we used two 
different computer softwares (Blast and siSPOTR) in which we checked the first 100 
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genes that may be influenced by our siRNA. Following this, we did a MicroArray 
analysis of three HF organ cultures from 3 different patients (data not shown) in which 
we compared the panel of genes affected by P-cadherin siRNA vs. scrambled oligos. 
These data demonstrated that none of the 100 genes that came out in the mentioned 
computer softwares, were affected in those 3 HF organ cultures.  
 
             Hair follicle melanocyte culture 
             Hair follicle melanocytes (HFMs) were isolated from normal human haired scalp 
tissue, obtained from a healthy adult Caucasian female (age 59 years) after elective 
plastic surgery with informed consent and with local ethics committee approval. All 
cell culture reagents were obtained from Invitrogen Ltd (Invitrogen Ltd, Paisley, 
Scotland) unless otherwise stated. Skin samples were collected in RPMI 1640 
medium and were processed within five hours of surgery. HFM cultures were 
established as described previously (Kauser et al., 2005). Briefly, EMEM 
supplemented with 2% FCS, 1x concentrated non-essential amino acid mixture, 100 
units/ml penicillin and 100 µg/ml streptomycin and 2 mM L-glutamine, 5 ng/ml 
endothelin-1and 5 ng/ml basic fibroblast growth factor (bFGF) was combined with 
keratinocyte serum free medium (K-SFM) supplemented with 25 mg/ml bovine 
pituitary extract (BPE), 0.2 ng/ml recombinant epidermal growth factor (rEGF), 100 
units/ml penicillin and 100 µg/ml streptomycin and 2 mM L-glutamine. Cells were 
incubated at 37ºC in a 5% CO2 atmosphere with medium replenished every third day. 
Contaminating fibroblasts, when present, were eliminated by treating the cultures with 
150 mg/ml geneticin sulphate (G418) for cycles of 48 hrs (Halaban and Alfano, 1984) 
and the identity of isolated cells was confirmed by immunophenotyping at passage 1 
with the melanocyte-lineage specific antibody NKI/beteb directed against 
glycoprotein100 (gp100) (Vennegoor et al., 1988). 
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Melanin histochemistry  
Briefly, cryosections and HFM cultures were air dried and fixed in ethanol-acetic acid. 
These were washed in Tris-buffered saline (TBS) and distilled water several times. 
Cryosections and HFMs were treated with ammoniacal silver solution (Fluka, Seelze, 
Germany) for 40 minutes (min) at 56
ο
C in the dark. After washing in distilled water, 
they were treated with 5% aqueous sodium thiosulphate (Merck, Darmstadt, 
Germany) for 1 min. Then, they were washed in running tap water for 3 min and were 
counterstained with haematoxylin for 45 seconds. After washing in distilled water, 
sections and HFMs were dehydrated and sections mounted in Eukitt (O. Kindler, 
Freiburg, Germany). Quantitative melanin histochemistry was conducted by 
measuring melanin content in a defined reference area in the hair matrix on both 
sides of the dermal papilla (DP). 14-15 HFs per group were evaluated from 3 different 
patients (2 patients with one transfection and one patient with two transfections with 
P-cadherin siRNA vs. scrambled oligos). 
In HFMs, melanin content was quantified as follows. After trypsinisation cells were 
counted using a Neubauer counting chamber, pelleted by centrifugation and 
solubilised in 1 M sodium hydroxide, boiled and melanin content measured 
spectrophotometrically at 475 nm. A standard curve of synthetic melanin (Sigma, 
Poole, Dorset, UK) was the basis for melanin content determination. Melanin content 
and cell counts were determined at least three times and average values were taken. 
Melanin content was measured as pg melanin per cell (i.e. HFMs) and expressed as 
percentage increase in melanin content above control cells. 
 
Immunohistochemistry (LSAB – Peroxidase)  
The cryosections were first air dried for 10 min and then fixed in acetone at -20
ο
C for 
another 10 min. After air drying for 10 min the slides were washed three times for 5 
min in TBS. Endogenous peroxidase blocking was achieved by putting the slides in 
3% hydrogen peroxide for 15 min, followed by three washing steps with TBS, 5 min 
each. The application of the different primary antibodies (Supplementary Table S1) 
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followed (in appropriate antibody diluents) (DCS Detection Line, Hamburg, Germany) 
overnight at 4
°
C. After washing three times for 5 min with TBS, sections were stained 
with polylink biotinylated secondary antibody (DCS Detection Line, Hamburg, 
Germany) for 20 min at room temperature (RT). After three washings for 5 min with 
TBS, a 20 min application of Horse Radish Peroxidase label (HRP) Avidin Biotin 
Complex (DCS Detection Line) followed, both at RT. Finally, the slides were labelled 
with 3-Amino-9-Ethylcarbazole (AEC) (DCS ChromoLine, Hamburg, Germany) and 
counterstained with haematoxylin with interspersed washing steps (Samuelov et al., 
2012). 
 
Immunofluorescence microscopy and quantitative 
immunohistomorphometry  
Immunfluorescence stainings for β –catenin, phospho- β –catenin and GSK3β were 
performed as described before (Samuelov et al., 2012). 
Immunfluorescence microscopy for SCF, gp100, c-Kit, MITF, ACTH and quantitative 
immunohistomorphometry are described in the following lines.  
For the SCF immunostaining, the slides were washed with phosphate buffered saline 
(PBS), cryosections were incubated overnight at 4
ο
C with the primary antibodies in 
the respective  
dilutions in antibody diluent (DCS Detection Line, Hamburg, Germany) 
(Supplementary Table S1) followed by incubation of 45 minutes (min) at room 
temperature (RT) with FITC-labeled goat anti-mouse (Jackson Immunoresearch 
Laboratories, West Grove, PA, USA), 1:200 in antibody diluent (DCS Detection Line). 
Incubation steps were interspersed with three washes, 5 min each.  
For gp100 staining, cryosections were first fixed in acetone and after washing steps 
with PBS, were incubated with the primary antibody (Supplementary Table S1) diluted 
in Dako antibody diluent (Dako, Glostrup, Denmark) overnight at 4
ο
C. The 
cryosecions were then incubated with a secondary rhodamine-labeled goat anti-
mouse antibody (Jackson Immunoresearch Laboratories), 1:200 in PBS and goat 
normal serum, for 45 min at RT, after washing steps.  
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For MITF staining, after fixation with acetone at -20°C and washing with TBS, 
cryosections were incubated overnight at 4
ο
C with the primary antibody 
(Supplementary Table S1) in the respective dilution in Dako antibody diluent (Dako), 
followed by incubation of 45 min at RT with FITC-labeled Rabbit anti-mouse IgG 
(Jackson Immunoresearch Laboratories) diluted 1:200 in TBS and normal rabbit 
serum. 
For ACTH staining, cryosections were first fixed in acetone and after washing steps 
with PBS, were incubated with the primary antibody (Supplementary Table S1) diluted 
in Dako antibody diluent (Dako) for one hour at 37
ο
C. The cryosecions were then 
incubated with a secondary FITC-labeled goat anti-rabbit antibody (Jackson 
Immunoresearch Laboratories), 1:200 in PBS and goat normal serum, for 45 min at 
RT, after washing steps.  
Since c-Kit is expressed on various cell types including melanocytes and the SCF-c-
Kit signaling play a key role in the control of hair pigmentation (Botchkarev et al., 
1999; Hachiya et al., 2009; Slominski et al., 1998), c-Kit immunoreactivity was 
investigated by using the highly sensitive immunofluorescent TSA technique (Perkin 
Elmer, Boston, MA, USA) (Roth et al., 1999). Briefly, cryosections of human HFs 
were incubated with the primary antibody (Supplementary Table S1) diluted in 
antibody diluent (DCS Detection Line), overnight at 4
ο
C, followed by incubation with a 
biotinylated antibody against rabbit IgG (Jackson immunoresearch Laboratories) 
(1:200 in antibody diluent, 45 min, RT). Next, streptavidin–horseradish peroxidase 
was administered (1:100 in Tris-NaCl-Tween Buffer, 30 min, RT). Finally, the reaction 
was amplified by tetramethylrhodamine.  
In addition, α-MSH immunoreactivity was also investigated by using the highly 
sensitive immunofluorescent TSA technique. Briefly, cryosections of human HFs were 
incubated with the primary antibody (Supplementary Table S1) diluted in TNB, 
overnight at 4
ο
C, followed by incubation with a biotinylated antibody against rabbit 
IgG (Jackson immunoresearch Laboratories) (1:200 in TNB, 45 min, RT). Next, 
streptavidin–horseradish peroxidase was administered (1:100 in Tris-NaCl-Tween 
Buffer, 30 min, RT). Finally, the reaction was amplified by tetramethylrhodamine. 
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The immunostaining intensity levels for the examined antigens were compared by 
quantitative immunohistochemistry as previously described (Ito et al., 2005a; Ito et al., 
2005b; Peters et al., 2005), using NIH image software (NIH, Bethesda, MD, USA). 
Three reference areas were defined (1, innermost hair matrix; 2, precortical hair 
matrix; 3, ORS) and analysis was performed in the specific area according to the 
antigen expression.  
 
Tyrosinase activity and melanocyte apoptosis in situ  
The tyramide-based tyrosinase assay was used for measuring tyrosinase activity in 
situ as previously described (Han et al., 2002; Kloepper et al., 2010). In this 
procedure, tyrosinase reacts with biotinyl tyramide, causing the substrate to deposit 
near the enzyme. These biotinylated deposits are then visualized with streptavidin 
conjugated to a fluorescent dye. This assay is highly specific and serves as a 
sensitive indicator of tyrosinase activity, which is restricted to melanogenically active 
melanocytes of the HF pigmentary unit (Tobin, 2011).  
 
In order to exclude confounding influences of HF cycling on pigmentation [note that 
HF melanogenesis is strictly coupled to the anagen stage of the hair cycle and is 
switched-off during catagen (Schneider et al., 2009; Slominski et al., 2005; Tobin, 
2011)], and in view of the fact that P-cadherin silencing prematurely induces catagen 
(Samuelov et al., 2012), we exclusively analyzed melanogenically fully active anagen 
VI HFs. To reliably determine the hair cycle stage of the examined HFs, the stringent, 
standardized hair cycle assessment criteria were employed including the evaluation 
of hair matrix proliferation and apoptosis a in the two treatment groups by Ki-
67/TUNEL double immunolabeling see (Kloepper et al., 2010). 
 
gp100/TUNEL double-IF 
Briefly, after fixation in 1% paraformaldehyde [in phosphate buffered saline (PBS)] 
and post-fixation in ethanol-acetic acid (2:1) (with washing steps in between), the 
sections were incubated first with anti TDT-Enzyme (TUNEL; ApopTag Fluorescein In 
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Situ Apoptosisdetection kit; Millipore, Berlin, Germany) as described previously (Bodo 
et al., 2004; Kloepper et al., 2008; Peters et al., 2006), and after washing steps and 
pre-incubation with goat serum and PBS, were incubated with mouse anti-human 
NKI/beteb (Monosan, Uden, Netherlands), diluted 1:20 in PBS and goat serum, 
overnight at 4
ο
C. As secondary antibodies, we used first anti-digoxigenin according to 
the manufacture's protocol (ApopTag Fluorescein In Situ Apoptosisdetection kit; 
Millipore), and secondly rhodamine-coupled goat anti-mouse IgG (Jackson 
immunoresearch Laboratories), diluted 1:200 in PBS and goat serum, 45min at RT.  
In all immunofluorescence staining methods, sections were counterstained with 4'-6-
Diamidino-2-phenylindole (DAPI) in a concentration of 1µg/ml (1 min at RT) for 
identification of cell nuclei. 
 
             Quantitative Real-Time PCR (qRT-PCR) 
Total RNA was extracted from whole organ cultured HFs using TRIreagent and 
digested with recombinant RNase-free DNase-1 (both from Applied Biosystems, 
Foster City, CA, USA) according to the manufacturer’s protocol. After isolation, one 
µg of total RNA was reverse-transcribed into cDNA by using High Capacity cDNA kit 
(Applied Biosystems) following the manufacturer’s protocol. PCR amplification was 
performed by using specific TaqMan primers and probes (Applied Biosystems, assay 
IDs: Hs00165976_m1 for human tyrosinase, Hs00241497_m1 for human SCF, 
Hs00173854_m1 for human gp100, Hs01117294_m1 for human MITF, 
Hs00174947_m1 for human proopiomelanocortin (POMC) and Hs00610344_m1 for   
human axin2). As internal housekeeping gene controls, transcripts of glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), peptidylprolyl isomerase A (PPIA) or β-actin 
were determined (Assay IDs: Hs99999903 for human ACTB, Hs99999904 for human 
PPIA and Hs99999905_m1 for human GAPDH). The amount of the above mentioned 
transcripts was normalized to those of the control genes using the ∆CT method.  
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Statistical analysis  
Quantitative immunohistochemistry data were expressed as mean ± SEM and 
analyzed by Mann–Whitney test (GRAPHPAD PRISM version 4.00 for Windows; 
GraphPad Software, San Diego, CA, USA). All qRT-PCR results were analysed by 
Student’s t test for unpaired samples. PCR results were normalized to glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), peptidylprolyl isomerase A (PPIA) or β-actin 
(Samuelov et al., 2012). 
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Supplementary Figures 
Supplementary Figure S1 
 
 
             Supplementary Figure S1. gp100/TUNEL double-immunofluorescence 
No evidence of hair follicle melanocyte apoptosis in both P-cadherin siRNA (b) and 
scrambled oligos (a) treated anagen hair bulbs. Red immunofluorescence (IF) is for 
gp100 and green IF is for TUNEL staining.  DP – dermal papilla. 
 
  
            
 
 
 
 
 
 
 
 
 
 
 
   Supplementary Figure S2 
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             Supplementary Figure S2. Effects of P-cadherin silencing on melanosome     
             transfer by Transmission Electron Microscopy  
(a) The hair follicle (HF) pigmentary unit (HFPU) in a scrambled oligos-treated HF. 
The melanosomes are efficiently transferred to the adjacent keratinocytes with no 
evidence of blockade in melanosome transfer. The inserted image demonstrates in 
higher magnification the presence of melanosomes inside the keratinocytes (arrow 
head).  
(b) The HFPU in a P-cadherin siRNA-treated HF. The melanocytes contain a huge 
number of melanosomes with significantly reduced melanosomes in the adjacent 
keratinocytes. Arrow heads represent melanosomes inside a melanocyte. Note the 
normally appearing melanocyte. 
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    Supplementary Figure S3 
 
Supplementary Figure S3. The effects of P-cadherin knockdown on epidermal 
pigmentation  
2mm skin punches were transfected with P-cadherin siRNA vs. scrambled oligos. P-
cadherin knock-down was confirmed both at the mRNA and protein level (Samuelov 
et al., 2012). All measurements were done by comparing the expression in the basal 
layer of the epidermis, in both treatment groups of skin punches. 
(a-c) No significant difference was found in melanin content by Masson-Fontana. 
(d-f) No significant difference was found in gp100 expression.  
(g-i) No significant difference was found in tyrosinase activity in situ.  
BL – basal layer; DR – dermis. 
           
 
 
Supplementary Figure S4. 
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Supplementary Figure S4. The effects of P-cadherin knockdown on Phospho-β-
catenin expression 
(a,b) Phospho-β-catenin immunoreactivity in scrambled oligos, P-cadherin siRNA, P-
cadherin siRNA+lithium chloride (LiCl) and LiCl treated hair follicles (HFs). Note the 
significant reduction in immunoreactivity by simultaneous treatment with LiCl and P-
cadherin siRNA.  
*p<0.05; **p<0.01; ***p<0.001, Mann Whitney test, n=4-9 HFs. 
Cad. – cadherin; IR – immunoreactivity; LiCl – lithium chloride; P-β-catenin - 
phospho-β-catenin; Scr. – scrambled. 
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Supplementary Figure S5  
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Supplementary Figure S5. Effect of P-cadherin silencing on expression of 
proopiomelanocortin, alpha-melanocyte stimulating hormone and 
adrenocorticotropic hormone        
             (a) No significant difference between the P-cadherin siRNA and scrambled oligos 
treated hair follicles (HFs) was demonstrated in proopiomelanocortin (POMC) mRNA 
level.  
(b,d-e) No significant difference between the P-cadherin siRNA and scrambled oligos  
treated HFs was demonstrated in alpha-melanocyte stimulating hormone (α-MSH) 
protein level. α-MSH expression was evaluated in the outer root sheath (ORS) 
keratinocytes  
(c,f-g) No significant difference between the P-cadherin siRNA and scrambled oligos 
treated HFs was demonstrated in adrenocorticotropic hormone (ACTH) protein level. 
ACTH immunoreactivity was measured both at the ORS and the innermost hair matrix 
keratinocytes. The white lines encircle the dermal papilla.  
α-MSH – alpha-melanocyte stimulating hormone; ACTH – adrenocorticotropic 
hormone; Cad. – cadherin; DP – dermal papilla; HS – hair shaft; IHM – innermost hair 
matrix; IR – immunoreactivity; ORS – outer root sheath; POMC – 
proopiomelanocortin; Scr. – scrambled. 
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Supplementary Figure S6. 
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Supplementary Figure S6. A hypothetical scenario: How P-cadherin may impact 
on melanocytes within the human hair follicle pigmentary unit 
(a) A normal state with intact P-cadherin. P-cadherin connects the melanocytes and 
the keratinocytes in the area of the follicular pigmentary unit. In a normal state, the 
Wnt signaling pathway is active both in the melanocytes and the keratinocytes, 
resulting in normal stem cell factor (SCF) (in the keratinocytes) and microphthalmia-
associated transcription factor (MITF) (in the melanocytes) expression and a 
corresponding upregulation of c-Kit, tyrosinase activity, gp100, follicular 
melanogenesis and normal transfer of melanosomes to the adjacent keratinocytes.  
(b) A state of P-cadherin absence (due to silencing, down regulation or mutation as in 
HJMD patients). P-cadherin knockdown in both melanocytes and keratinocytes 
results in increased degradation of β-catenin and reduced β-catenin target genes 
expression. This causes reduced MITF expression in the melanocytes, while in the 
keratinocytes probably reduced SCF is expressed and secreted with the 
correspondence down regulation of c-Kit on the surface of adjacent melanocytes. 
Reduction of c-Kit expression and signaling reduces MITF expression and 
phosphorylation of cAMP responsive element binding protein (CREB), another cause 
for MITF down regulation, unrelated to the canonical Wnt signaling pathway. 
Reduction in MITF expression results in down regulation of tyrosinase activity, gp100 
expression and hair follicle (HF) melanogenesis. In addition, P-cadherin slencing 
results in reduced melanosome transfer to the adjacent keratinocytes in the HF 
pigmentary unit. 
ME – melanosome; MITF - microphthalmia-associated transcription factor; P-CREB – 
phosphorylated cAMP responsive element binding protein; P-cad. – P-cadherin; SCF 
– stem cell factor. 
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Primary 
antibody 
clone Origin References 
Ig 
class 
Dilution Company 
Secondary 
detection 
system 
P-cadherin 56 Mouse 
(Kovacs and 
Walker, 2003; 
Paredes et al., 
2005) 
IgG1 1:50 
BD Transduction 
Laboratories, 
Heidelberg, 
Germany 
LSAB-PR 
β-catenin 14 Mouse 
(Tsuji et al., 
2001) 
IgG1 1:50 
BD Transduction 
Laboratories, 
Heidelberg, 
Germany 
LSAB-PR, 
IF-FITC 
GSK3β 7 Mouse 
(Bijur and Jope, 
2001; Lucas et 
al., 2001) 
IgG1 1:20 
BD Transduction 
Laboratories, 
Heidelberg, 
Germany 
IF-FITC 
Phospho-β-
catenin 
(Ser33/37/Thr41) 
 Rabbit 
(Kielhorn et al., 
2003; 
Nakopoulou et 
al., 2006) 
PA 1:50 
Cell Signaling, 
Danvers, MA, USA 
LSAB-PR, 
IF-FITC 
SCF hKL12 Mouse 
(Puputti et al., 
2010; Sihto et 
al., 2007) 
IgG1 1:20 
Acris antibodies, 
Hiddenhausen, 
Germany 
IF-FITC 
gp100 NKI/beteb Mouse 
(Dhaene et al., 
2000; Kloepper 
et al., 2010) 
 
IgG2b 
1:30 
Monosan, Uden, 
Netherlands 
IF - Rh 
MITF D5 Mouse 
(Zhuang et al., 
2007) 
IgG1 1:50 
Dako, Glostrup, 
Denmark 
IF-FITC 
ACTH  Rabbit 
(Sakai et al., 
2003; Slominski 
et al., 1993) 
PA 1:30 
Chemicon, 
Temecula, CA, 
USA 
IF-FITC 
c-Kit YR145 Rabbit 
(Vila et al., 
2009) 
IgG 1:1000 
Cell Marque, 
Rocklin, CA, USA 
TSA 
α-MSH  Rabbit 
(Kono et al., 
2001) 
PA 
1:500 
 
Sigma, Munich, 
Germany 
TSA 
Supplementary Table S1  
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            Supplementary Table S1. Antibodies used for immunohistological stainings are listed 
and described in detail. α-MSH - α-Melanocyte-stimulating hormone; ACTH -  
Adrenocorticotropic hormone; FITC - fluorescein isothiocyanate; GSK3β - Glycogen 
synthase kinase 3 beta; IF - immunofluorescence; LSAB-PR - Labeled Streptavidin 
Biotin Peroxidase; MITF - microphthalmia-associated transcription factor; PA – 
polyclonal antibody; Rh - rhodamine; SCF - stem cell factor; TSA - tyramide signal 
amplification conjugated.  
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P-Cadherin Regulates Human Hair Growth
and Cycling via Canonical Wnt Signaling and
Transforming Growth Factor-b2
Liat Samuelov1,2, Eli Sprecher1,3, Daisuke Tsuruta4, Tama´s Bı´ro´5, Jennifer E. Kloepper2,7 and Ralf Paus2,6,7
P-cadherin is a key component of epithelial adherens junctions, and it is prominently expressed in the hair
follicle (HF) matrix. Loss-of-function mutations in CDH3, which encodes P-cadherin, result in hypotrichosis with
juvenile macular dystrophy (HJMD), an autosomal recessive disorder featuring sparse and short hair. Here, we
attempted to recapitulate some aspects of HJMD in vitro by transfecting normal, organ-cultured human scalp
HFs with lipofectamine and CDH3-specific or scrambled control siRNAs. As in HJMD patients, P-cadherin
silencing inhibited hair shaft growth, prematurely induced HF regression (catagen), and inhibited hair matrix
keratinocyte proliferation. In situ, membrane b-catenin expression and transcription of the b-catenin target
gene, axin2, were significantly reduced, whereas glycogen synthase kinase 3 b (GSK3b) and phospho-b-catenin
immunoreactivity were increased. These effects were partially reversed by inhibiting GSK3b. P-cadherin
silencing reduced the expression of the anagen-promoting growth factor, IGF-1, whereas that of transforming
growth factor b 2 (TGFb2; catagen promoter) was enhanced. Neutralizing TGFb antagonized the catagen-
promoting effects of P-cadherin silencing. In summary, we introduce human HFs as an attractive preclinical
model for studying the functions of P-cadherin in human epithelial biology and pathology. This model
demonstrates that cadherins can be successfully knocked down in an intact human organ in vitro, and shows
that P-cadherin is needed for anagen maintenance by regulating canonical Wnt signaling and suppressing
TGFb2.
Journal of Investigative Dermatology advance online publication, 14 June 2012; doi:10.1038/jid.2012.171
INTRODUCTION
P-cadherin is a member of the classical cadherin family and a
key component of adherens junctions in various epithelia,
including the epidermis and hair follicles (HFs; Shimoyama
et al., 1989; Andl et al., 2002; Paredes et al., 2007). It has
major roles in cell recognition and signaling, morphogenesis,
and tumor development (Goodwin and Yap, 2004; Paredes
et al., 2007; Fanelli et al., 2008). It comprises five
extracellular domains, a transmembrane domain, and a small
intracellular domain that interacts with b-catenin. The latter is
a crucial factor in the canonical Wnt signaling pathway
(Nelson and Nusse, 2004; Fanelli et al., 2008; Heuberger
and Birchmeier, 2010; for details, see Figure 1a). As p63
directly interacts with the promoter for CDH3, the gene
that encodes P-cadherin, the latter is a p63 target gene
(Shimomura et al., 2008).
CDH3 mutations cause two autosomal recessive disorders,
hypotrichosis with juvenile macular dystrophy (HJMD;OMIM
601553) and ectodermal dysplasia, ectrodactyly and macular
dystrophy (EEM;OMIM 225280), which are associated with
hair abnormalities. Dermatologically, these patients show
sparse and short hair throughout life, an increased percentage
of HFs in the regression (catagen) or resting stage (telogen) of
the hair cycle, and abnormal hair shafts (Supplementary
Figure S1a–d online; Sprecher et al., 2001; Indelman et al.,
2002, 2007; Bergman et al., 2004; Kjaer et al., 2005; Leibu
et al., 2006; Shimomura et al., 2008, 2010; Jelani et al.,
2009). Although this suggests that P-cadherin is required for
normal hair growth, it remains unknown how P-cadherin
impacts the human HFs. Unfortunately, P-cadherin-deficient
mice fail to recapitulate the HJMD phenotype (Radice et al.,
1997). This suggests that the role of P-cadherin-mediated
signaling in human epithelial biology and pathology is best
studied directly in human HFs.
& 2012 The Society for Investigative Dermatology www.jidonline.org 1
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To do so, we have generated a previously unreported,
widely accessible in vitro-surrogate model of HJMD, based
on the use of organ-cultured human scalp HFs, a prototypic
ectodermal–mesodermal interaction unit (Paus and Cotsar-
elis, 1999; Schneider et al., 2009). Although, evidently, a
complex human genetic disorder cannot be expected to
be fully recreated in vitro, we hoped that such an in vitro
model could shed new light on how the hair phenotype
develops in HJMD patients and on the as yet obscure role of
P-cadherin signaling in human epithelial biology. Specifi-
cally, we asked how P-cadherin silencing in organ-cultured
human HFs affects hair growth, cycling, and hair shaft
formation. In addition, we aimed to obtain indications as to
which signaling pathway(s) P-cadherin may use to mediate its
HF effects.
RESULTS
P-cadherin expression is strongest in the innermost hair matrix
of human anagen HFs
First, we established the protein expression pattern of
P-cadherin in fully growing human HFs (i.e., in the anagen
VI stage of the hair cycle). Immunohistology showed that, just
as in mice (Muller-Rover et al., 1999), P-cadherin protein is
most prominently expressed in the innermost cell layer of the
human hair matrix (Figure 2a). This confirms the intrafolli-
cular P-cadherin expression pattern previously described
by Fujita et al. (1992). However, prominent P-cadherin
immunoreactivity was also seen throughout the human
epidermis, with sharply reduced expression in its proliferation
compartment, i.e., the basal layer of the epidermis (Supple-
mentary Figure S2a online). This is in contrast with previous
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Figure 1. Working hypothesis: P-cadherin regulates human hair growth via the canonical Wnt signaling pathway through b-catenin. (a) b-Catenin is found in
epithelial cells either bound to the cytoplasmic domain of classical cadherins or free in the cytoplasm. In the absence of Wnt ligands, excess cytoplasmic b-
catenin is recruited to a destruction complex that contains adenomatous polyposis coli (APC), axins, and glycogen synthase kinase 3 b (GSK3b). b-Catenin gets
phosphorylated by this complex and is targeted for proteosomal degradation. In the presence of Wnt ligands, the destruction complex is inactivated. This leads to
an increase of cytoplasmic b-catenin and its translocation into the nucleus, where it binds lymphoid enhancer–binding factor 1 (LEF1) and T-cell factor (Tcf). b-
Catenin/LEF/Tcf complexes control the expression of genes involved in the control of hair morphogenesis and cycling, including axin2 and IGF1. For greater
simplicity, the reported regulation of P-cadherin by p63 (Shimomura et al., 2008) is not shown here. (b) The absence of P-cadherin. Canonical Wnt signaling and
cadherin-mediated cell adhesion depend on the same cytoplasmic pool of b-catenin (Gottardi and Gumbiner, 2001). P-cadherin absence (P-cadhein
knockdown or in hypotrichosis with juvenile macular dystrophy patients) results in over-degradation of cytoplasmic b-catenin and reduced b-catenin-dependent
Wnt target gene expression. a, a-catenin; b, b-catenin; FZ, Frizzled; IC, intracytoplasmic domain of P-cadherin; P-phospho; TGFb, transforming growth factor b;
Ub, ubiquitin.
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reports in both mice and humans that state that P-cadherin
expression is largely confined to the epidermal basal layer
(Hirai et al., 1989; Fujita et al., 1992).
P-cadherin expression declines during catagen
As hair cycle–dependent changes in the expression level of
molecules during the HF transformation from growth (ana-
gen) to apoptosis-driven HF regression (catagen) frequently
indicate a functional role of the molecule under investigation
during this organ transformation process (Stenn and Paus,
2001; Schneider et al., 2009), we also examined whether
constitutive P-cadherin expression differs between human
anagen VI and catagen HFs. Indeed, P-cadherin expression
sharply declines during spontaneous, apoptosis-driven HF
regression (catagen), both at the protein (Supplementary
Figure S2b–c online) and transcript steady state (Figure 2b)
levels. This regulated, hair cycle–dependent intrafollicular
P-cadherin expression pattern suggests a functional role for
P-cadherin during the anagen–catagen transformation, the
clinically most important phase in HF cycling (Paus and
Foitzik, 2004; Schneider et al., 2009).
P-cadherin knockdown is possible in human HFs and human
skin organ culture
Next, we attempted to silence P-cadherin expression in
organ-cultured human anagen scalp HFs (Kloepper et al.,
2010) and full-thickness human scalp skin fragments
(Lu et al., 2007). P-cadherin gene knockdown was performed
by transfection with CDH3-specific or scrambled control
siRNAs, using lipofectamine. Successful in situ knockdown of
P-cadherin was documented at the gene and protein levels in
both organ-cultured human scalp HFs (Figure 2c–f) and the
epidermis (Supplementary Figure S2d–g online). No signifi-
cant difference in E-cadherin expression was documented
following P-cadherin knockdown, indicating the specificity
of silencing (Supplementary Figure S2h–j).
To the best of our knowledge, successful knockdown of a
cadherin family member in an intact human organ
has not previously been reported. This invites exploitation
of organ-cultured human HFs and skin as attractive pre-
clinical models for dissecting the molecular and cellular
consequences of P-cadherin loss of function in situ. Avail-
ability of such an experimental model constitutes a significant
methodological advance, as the functions of P-cadherin
mediated signaling in human epithelial physiology are as yet
ill-understood (Faraldo et al., 2007; Shimomura et al., 2008;
Bandara et al., 2010; Jacobs et al., 2011).
P-cadherin silencing results in premature catagen induction and
hair growth inhibition
As the prominent clinical and histological features of HJMD
patients are short and sparse hair since birth, associated with
miniaturization and telogen HFs (Supplementary Figure
S1a–d), we next examined whether P-cadherin knockdown
results in any changes of human hair growth and/or cycling.
As assessed by quantitative hair cycle histomorphometry
and Ki-67 immunohistomorphometry, this was the case:
in vitro P-cadherin knockdown prematurely induced catagen
development in microdissected organ-cultured human ana-
gen VI scalp HFs (Figure 2g–l). This was independently
confirmed by quantitative Masson–Fontana histochemistry
(Kloepper et al., 2010), which revealed the expected sharp
reduction in the HF melanin content (data not shown) as a
result of the catagen-associated switch-off of intrafollicular
melanogenesis (Slominski et al., 2005). Furthermore, P-
cadherin silencing in vitro resulted in significant inhibition
of hair shaft growth (Figure 3).
Therefore, P-cadherin knockdown in healthy human scalp
HFs in vitro partially recapitulates the hair growth inhibition
that is seen in HJMD patients with mutated CDH3 in vivo
(Sprecher et al., 2001). This was associated with a significant
inhibition of hair matrix keratinocyte proliferation in catagen
and anagen HFs (see Figure 2k–l), which explains the reduced
rate of hair shaft formation and is in line with the observed
premature catagen development in P-cadherin-silenced
human HFs.
Ultrastructurally, P-cadherin silencing causes HF dystrophy
The hair growth inhibitory effect of P-cadherin silencing
in situ was followed up at the ultrastructural level. Transmis-
sion electron microscopy showed that, compared with
scrambled-control-treated HFs, P-cadherin-silenced HFs con-
tain large, abnormal aggregates of keratin clumps inside the
cytoplasm of precortical hair matrix keratinocytes (Supple-
mentary Figure S3a–b online), whereas no ultrastructural
abnormalities were detected in the hair shaft cortex and
medulla, except for narrower intercellular spaces (Supple-
mentary Figure S3c–f online).
Quantitative TUNEL immunohistomorphometry showed
that the number of apoptotic keratinocytes in the precortical
hair matrix is not significantly higher than that in control HFs
treated with scrambled oligos (data not shown). Therefore,
the observed keratin clumping phenomenon suggests a defect
in the correct intracellular transport and arrangement of
keratin filaments in the absence of adequate P-cadherin
levels/signaling, and is unlikely to result indirectly from
enhanced, catagen-associated hair matrix keratinocyte apop-
tosis. The concept of a defect in keratin transport and
arrangement is also in line with the observed HF dystrophy
and reduced hair shaft formation.
P-cadherin silencing impairs normal hair keratin expression
To obtain additional pointers to how P-cadherin silencing
may impair hair shaft formation and may cause HF dystrophy,
gene expression profiling was performed. Q-PCR analysis
revealed that three different hair keratins (KRT36, KRT37, and
KRT84) are significantly upregulated by P-cadherin silencing
(Supplementary Figure S4a–c online). Although this remains
to be functionally tested, this abnormal hair keratin expres-
sion profile may relate to the observed hair shaft inhibition
in vitro (Figure 3) and/or to the abnormal hair phenotype seen
in HJMD patients in vivo (Supplementary Figure S1a–b
online; Sprecher et al., 2001; Bergman et al., 2004). These
transcriptional observations, which need to be confirmed
on the protein level, make it conceivable that, in the absence
of functional P-cadherin signaling, overexpression and/or
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miscombination of selected hair shaft keratins can impair hair
shaft structure and resilience.
P-cadherin silencing affects the expression of prominent hair
cycle regulators
Subsequently, we explored whether the P-cadherin silencin-
g–induced hair cycle abnormality goes along with changes in
two key hair cycle regulatory growth factors, i.e., insulin-like
growth factor-1(IGF-1) and transforming growth factor b 2
(TGFb2; Philpott et al., 1994; Stenn and Paus, 2001; Soma
et al., 2002; Hibino and Nishiyama, 2004; Weger and Schlake,
2005; Schneider et al., 2009). The steady-state mRNA level of
IGF-1, the key growth factor that maintains HFs in anagen
(Philpott et al., 1994; Ben Amitai et al., 2006; Kwack et al.,
2009; Zhao et al., 2011), significantly declines after P-cadherin
knockdown (Figure 4a).
In contrast, the immunoreactivity of TGFb2, the key
catagen-inducing growth factor (Hibino and Nishiyama,
2004), significantly increases in P-cadherin-silenced HFs
(Figure 4b–d). This TGFb upregulation is functionally
important, as the effects of P-cadherin knockdown on HF
growth and cycling can be partially reversed by culturing
P-cadherin-silenced HFs in the presence of TGFb-neutraliz-
ing antibody (Supplementary Figure S5a–d online). Thus,
P-cadherin-mediated signaling may be required to maintain
human HFs in anagen, at least in part, via suppressing
TGFb2 expression and by maintaining sufficient IGF-1
levels.
P-cadherin silencing regulates canonical Wnt signaling
P-cadherin and the Wnt signaling pathway rely on the same
pool of cytoplasmic b-catenin (Gottardi and Gumbiner, 2001;
Kuphal and Behrens, 2006; Heuberger and Birchmeier, 2010;
Figure 1a), and adequate Wnt signaling is thought to be
important for anagen maintenance in murine HFs (Van Mater
et al., 2003; Shimizu and Morgan, 2004; Schneider et al.,
2009; Li et al., 2011). Therefore, we finally investigated
whether P-cadherin silencing affects b-catenin stabilization
and Wnt target gene expression in human keratinocytes of the
innermost hair matrix, i.e., the site of maximal intrafollicular
P-cadherin expression (see Figure 2a). To this end, b-catenin
and glycogen synthase kinase 3 b (GSK3b) expression was
assessed immunohistologically.
After intrafollicular P-cadherin silencing, membrane
b-catenin immunoreactivity is significantly reduced, whereas
GSK3b and phospho-b-catenin protein expression is signifi-
cantly increased in situ (Figure 5a–g). Therefore, P-cadherin
silencing in keratinocyes of the innermost hair marix
significantly upregulates b-catenin degradation, likely
through GSK3b. This is expected to result in reduced active
b-catenin available for the Wnt signaling pathway (Figure
1b). Further evidence of reduced b-catenin activity by P-
cadherin knockdown was obtained by demonstrating that
transcription of a key b-catenin target gene, axin 2 (Lovatt and
Bijlmakers, 2010), is reduced in silenced HFs (Figure 5h).
These effects (i.e., axin2 downregulation and phospho-b-
catenin upregulation following P-cadherin knockdown) are
partially reversed by culturing P-cadherin-silenced HFs in the
presence of the potent GSK3b inhibitor, lithium chloride
(Tighe et al., 2007; Figure 5i–k).
Taken together, these experiments demonstrate P-cadherin
to be a key regulator of canonical Wnt signaling in human
HFs, whose maintenance appears to be critical for sustaining
HFs in their growth phase (anagen).
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DISCUSSION
Here we provide early evidence that P-cadherin protein
expression and its presence in adherens junctions is essential
for normal epithelial growth in an intact human organ.
Specifically, we document that P-cadherin operates as a
potent regulator of human hair shaft formation and hair
growth. It has not been shown directly before that a member
of the cadherin family has an essential regulatory role in the
control of normal human HF growth and cycling.
Our data suggest that P-cadherin maintains human HFs in
anagen through activation of canonical Wnt signaling and
operates as a major molecular brake on HF regression
(catagen) by inhibiting GSK3b-mediated b-catenin degrada-
tion, thereby ensuring active canonical Wnt signaling (Figure
1a). This is well in line with the increasing recognition that
canonical Wnt signaling is crucial for murine hair growth
(Huelsken et al., 2001; Andl et al., 2002; Millar, 2002; Van
Mater et al., 2003; Shimizu and Morgan, 2004; Schneider
et al., 2009; Baker et al., 2010; Li et al., 2011). This concept is
supported by our findings that P-cadherin maintains expres-
sion of the anagen-promoting growth factor IGF-1, whereas it
suppresses the chief catagen-promoting growth factor TGFb2.
The current experiments suggest that if normal P-cadherin-
mediated signaling is antagonized by gene silencing, or
becomes dysfunctional owing to CDH3 gene mutations
(HJMD), this results in a decrease of membrane-bound b-
catenin. The latter is likely released from the cadherin–catenin
complex in hair matrix keratinocytes and is targeted for
ubiquitination and degradation, as attested by the observed
upregulation of GSK3b and phospho-b-catenin after P-
cadherin silencing. This, in turn, is expected to sharply reduce
the amount of cytoplasmic b-catenin available for canonical
Wnt signaling, thus resulting in the downregulation of key b-
catenin target genes required for anagen maintenance (for
details, see Figure 1b) (Huelsken et al., 2001; Andl et al.,
2002; Schneider et al., 2009; Baker et al., 2010).
P-cadherin knockdown did not reveal any significant
change of intraepidermal b-catenin expression, compared
with human skin fragments treated with scrambled oligos
(Supplementary Figure S6 online). This suggests that the
effects of P-cadherin silencing on b-catenin (and Wnt
signaling) are HF specific and do not necessarily apply to
other compartments of the human skin epithelium that
normally express P-cadherin (Supplementary Figure S2a
online). The principle that cadherin family members can
impact Wnt activity is further supported by recent studies that
demonstrate that in vivo knockdown of N-cadherin reduces b-
catenin signaling and that E-cadherin depletion diminishes
Wnt-related transcriptional activity (Casagolda et al., 2010;
Zhang et al., 2010; Howard et al., 2011).
Although it is extremely difficult to obtain sufficient
amounts of human HFs to permit western blot analyses of
inner hair matrix proteins, the latter would be desirable to
independently confirm the quantitative immunohistomorpho-
metry in situ data on phospho-b-catenin presented here by
quantitative biochemical evidence.
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The observed keratin clumping (Supplementary Figure S3a
online) may result from defective intracellular transport and
arrangement of keratin filaments in the absence of adequate
P-cadherin levels/signaling. This fits well to the observed HF
dystrophy and reduced hair shaft formation, and is in line
with the concept that P-cadherin is a direct p63 target gene
(Shimomura et al., 2008), as p63 constitutes a crucial control
of normal keratinization (Kim et al., 2009; Mikkola et al.,
2010). Perhaps this p63 connection also explains the
abnormal hair keratin gene expression seen after P-cadherin
silencing (Supplementary Figure S4a–c online).
Just as in murine HFs (Muller-Rover et al., 1998), P-
cadherin is the only classical cadherin that is physiologically
expressed in the innermost hair matrix, i.e., at the key
epithelial interface with the inductive HF mesenchyme
(Figure 2a, Supplementary Figure S2h–j online). Therefore, it
is conceivable that this special epithelial HF compartment
depends on adequate P-cadherin signaling for normal
epithelial cell function and anagen maintenance. This may
render hair matrix keratinocyte proliferation, terminal kera-
tinocyte differentiation in the precortical hair matrix, and
consequently hair shaft formation from this cell pool very
sensitive to P-cadherin silencing and P-cadherin genetic
dysfunction.
Our data also suggest that the innermost cell layer of the
matrix has the capacity to regulate the human hair cycle
independently of epithelial stem cells in the—much more
distally located—HF bulge (which is absent under the current
HF organ culture conditions). Therefore, this region of the hair
matrix must generate as yet unknown P-cadherin-dependent
signals that impact on whether a HF stays in anagen or enters
into catagen and which translate into changes in the
intrafollicular balance between anagen-maintaining and
catagen-promoting growth factors (e.g., IGF-1 vs. TGFb2).
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To elucidate these P-cadherin-dependent signals that have an
impact on and/or emanate from the innermost hair matrix,
certainly, is an important future research target. Moreover, the
present study paves way for the development of a potential
new class of human hair growth inhibitors, namely P-cadherin
inhibitory agents, as a previously unreported strategy for the
management of hirsutism.
P-cadherin expression was also demonstrated in retinal
pigment epithelium of mice (Xu et al., 2002) and humans
(Burke et al., 1999). Therefore, it is interesting to note that a
key feature of HJMD patients is progressive macular
degeneration leading to blindness in the third decade of life.
This raises the intriguing, speculative question whether P-
cadherin may have an important role in the—insufficiently
understood—pathogenesis of age-related macular degenera-
tion, the leading cause of blindness in the adult population in
the Western world (Gragoudas et al., 2004).
The effects of P-cadherin silencing in normal adult human
scalp HFs in vitro correspond well to the hair phenotype of
patients with HJMD and EEM syndromes, who characteristically
exhibit an abnormally high percentage of catagen HFs and
show retarded/reduced hair shaft formation (Sprecher et al.,
2001; Bergman et al., 2004). Therefore, our study also provides
a clinically relevant in vitro-surrogate model for studying (a) the
general consequences of P-cadherin loss of function in human
epithelial biology in situ and (b) the pathomechanisms that
underlie the complex and as yet ill-understood hair phenotypes
seen in HJMD and EEM patients.
MATERIALS AND METHODS
Tissue collection
Human anagen VI HFs were isolated from scalp skin obtained from
six patients undergoing routine face-lift surgery (one man and five
women aged 42–59 years; mean age 50 years) after written, informed
consent and adherence to the Declaration of Helsinki Principles.
P-cadherin knockdown
In four HF cultures, HFs were transfected once with human
P-cadherin siRNA (Sigma-Aldrich, Munich, Germany, SA-
SI_Hs02_00332561, 50-CCAAUAUCUGUCCCUGAAA-30) at day 0,
whereas in two additional cultures HFs were transfected twice, i.e.,
at days 0 and 3. HFs treated with control siRNA (scrambled oligos;
Santa Cruz Biotechnology, Santa Cruz, CA, sc-37007) served as
control. After transfection (and between the two transfections in the
two additional cultures mentioned above), HFs were maintained in a
24-well plate with 500 ml William’s E medium (Biochrom, Cam-
bridge, UK) supplemented with 1% L-glutamine (Invitrogen, Paisley,
UK), 0.02% hydrocortisone (Sigma-Aldrich), 0.1% insulin (Sigma-
Aldrich), and 1% antibiotic/antimycotic mixture (Gibco, Karlsruhe,
Germany; Philpott et al., 1990). All reagents required for transfection
were obtained from Santa Cruz Biotechnology (siRNA transfection
reagent, sc-29528; siRNA transfection medium, sc-36868). HF
transfection was performed according to the manufacturer’s protocol
(Santa Cruz Biotechnology).
Human HF and skin organ culture
Normally pigmented anagen VI HFs were microdissected and organ-
cultured under serum-free conditions in insulin- and hydrocortisone-
supplemented William’s E medium (Philpott et al., 1990; Kloepper
et al., 2010). Six HF organ cultures were prepared (each derived
from a separate patient; total HF number in each culture: 52–132).
Two full-thickness human skin organ cultures from two different
patients (aged 58 and 77 years) were also prepared as described
elsewhere (Lu et al., 2007; Bodo et al., 2010).
For each experiment, HFs were equally divided between those
treated with P-cadherin siRNA (test) or scrambled oligos (control).
In one culture, culture medium was also supplemented with 40 mM
lithium chloride (Sigma, Munich, Germany; either as the only
treatment, or 5–7 hours after transfection) or 5mg ml1 TGFb-
neutralizing antibody (monoclonal anti-TGFb1-3 antibody; R&D
systems, Wiesbaden, Germany; either as the only treatment or
simultaneously with the transfection). Lithium chloride was added
only once to the culture medium (5–7 hours after transfection), and
HFs were embedded 24 hours afterward. TGFb-neutralizing anti-
body was added first, 5–7 hours after transfection, and a concentra-
tion of 5mg ml1 was added every day in a 4-day culture period.
Hair shaft length was measured daily using an inverted binocular
microscope (Philpott et al., 1990), and culture medium was replaced
immediately after the transfection and then every other day. On days
2 and 4 (and also on day 3 in the two transfection cultures), samples
of culture medium were taken for measuring the lactate dehydro-
genase (LDH) level as a general cell toxicity parameter in human
skin organ culture (Lu et al., 2007). This showed no significant
increase in the LDH release of P-cadherin-silenced HFs compared
with HFs treated with scrambled oligo controls after a single
transfection, but demonstrated the expected rise in LDH levels after
repeated siRNA treatment (data not shown). This indicates minimal
toxicity after a single transfection, whereas repeated transfection
carries the expected risk of increased toxicity. At 24 hours after the
transfection (on day 1 in the one transfection cultures and on day 4
in the two transfection cultures), 12–25 HFs from each culture were
frozen in liquid nitrogen for RNA extraction and mRNA analysis. The
rest of the HFs in each culture were embedded in Shandon
Cryomatrix (Pittsburgh, PA) and snap-frozen in liquid nitrogen on
day 4 of culture. HFs that were treated with lithium chloride were
embedded 24 hours after the beginning of treatment.
Five to seven 6-mm-thick cryosections of organ-cultured human
HFs were prepared for subsequent immunohistology, and were
stored at 801C until use.
In the two skin organ cultures, 2-mm full-thickness skin punches
were transfected with P-cadherin siRNA and control siRNA at day 0
(six pieces per group) using a similar protocol as that used for HF
organ culture. In one culture, 24 hours after transfection, skin
punches were frozen in liquid nitrogen for RNA extraction and
mRNA analysis. In the second culture, skin punches were embedded
in Shandon Cryomatrix and snap-frozen in liquid nitrogen on day 4
of culture. Cryosections (7mm thick) of skin punches were cut for
immunohistological staining.
The efficacy of gene silencing was evaluated using P-cadherin-
specific immunohistochemistry and Q-PCR, both in the HF and skin
organ cultures.
Materials and Methods for supplementary data
Immunohistochemistry, apoptosis/proliferation assay, melanin
histochemistry, hair cycle staging, quantitative (immuno)histomor-
phometry, HJMD patient histology, quantitative real-time PCR
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(Q-PCR), transmission electron microscopy, and statistical analysis
can be found in the supplementary materials, online.
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Supplementary data 
 
Supplementary Materials and Methods 
 
Immunohistochemistry 
LSAB – peroxidase immunohistology 
The cryosections were first air-dried for 10 min and then fixed in acetone at -20
ο
C for another 
10 min. After air drying, the slides were washed three times for 5 min in Tris-buffered saline 
(TBS). Endogenous peroxidase blocking was achieved by putting the slides in 3% hydrogen 
peroxide for 15 min, followed by three washings with TBS, 5 min each. In the following step, 
the mouse anti-human P-cadherin monoclonal antibody and mouse anti-human β-catenin 
monoclonal antibody (both from BD transduction laboratories, Heidelberg, Germany, clones 
56 and 14 respectively), rabbit anti-human phospho-β-catenin (Ser33/37/Thr41) (Cell 
Signaling Technology, Danvers, MA, USA) in 1:50 dilution with antibody diluent (DCS 
Detection Line, Hamburg, Germany) and mouse anti-human E-cadherin monoclonal antibody 
(Invitrogen, Darmstadt, Germany, clone HECD1, predilute antibody) were put on the 
cryosections at 4
 ο
C overnight. After washing three times for 5 min with TBS, sections were 
stained with polylink biotinylated secondary antibody (DCS Detection Line) for 20 min at room 
temperature (RT). After three washings for 5 min with TBS, a 20 min application of horse 
radish peroxidase labeled (HRP) avidin biotin complex (DCS Detection Line) followed, both at 
RT. Finally, the slides were labelled with 3-amino-9-ethylcarbazole (DCS ChromoLine, 
Hamburg, Germany) and counterstained with haematoxylin with washing steps in between.  
 
For the P-cadherin staining, normal breast tissue was used as negative and positive control 
(Figure S7a). As positive controls we further used normal breast tissue (for E-cadherin) 
(Figure S7b) and normal epidermis (for GSK3β) as previously published (Kovacs et al., 2003; 
Yamaguchi et al., 2007). Positive staining of β-catenin in the human hair follicle (HF) by the 
same primary antibody employed here was previously demonstrated (Tsuji et al., 2001). 
Positive staining of phospho-β-catenin by the same antibody and with a similar 
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immunoreactivity pattern as seen here was previously published (Kielhorn et al., 2003; 
Nakopoulou et al., 2006). Negative controls were performed by deleting the primary 
antibodies, and by demonstrating negative immunoreactivity in cell compartments/tissues in 
accordance with the literature.  
 
Immunofluorescence 
In order to better localize β-catenin and phospho-β-catenin expression in the HF and also in 
order to demonsrate GSK3β IR, we used also immunofluorescence techniques. For β-catenin 
staining, after fixation with acetone at -20
ο
C and washing with TBS, cryosections were 
incubated overnight at 4
ο
C with the mouse anti-human β-catenin monoclonal antibody (BD 
transduction laboratories) in 1:50 dilution with TBS, followed by incubation of 45 min at RT 
with FITC-labeled goat anti-mouse IgG (Jackson Immunoresearch Laboratories, West Grove, 
PA, USA) diluted 1:200 in TBS and normal goat serum. For phospho-β-catenin and GSK3β 
staining, after washing the slides with phosphate buffered saline (PBS), cryosections were 
incubated overnight at 4
ο
C with the rabbit anti-human phospho-β-catenin (Ser33/37/Thr41) 
(Cell Signaling Technology) and mouse anti-human GSK3β (BD Transduction Laboratories) 
in 1:50 and 1:20 dilutions respectively with antibody diluents (DCS Detection Line). This was 
followed by incubation with FITC-labeled goat anti-mouse and goat anti-rabbit IgG (Jackson 
Immunoresearch Laboratories), respectively, for 45 min at RT in 1:200 in antibody diluent 
(DCS Detection Line). Incubation steps were interspersed with three washes, 5 min each. 
Then sections were stained with DAPI in a concentration of 1µg/ml (1 min at RT) for 
identification of cell nuclei. 
 
Since TGFβ2 is a recognized key inducer of catagen in human HFs (Soma et al., 2002), 
TGFβ2 expression in HFs treated with P-cadherin siRNA and control siRNA was investigated 
by using the highly sensitive immunofluorescent TSA technique (Perkin Elmer, Boston, MA, 
USA) (Roth et al., 1999). Briefly, cryosections of human HFs were incubated with rabbit anti-
human TGFβ2 (Santa Cruz Biotechnology Inc) as the primary antibody, diluted 1:4000 in Tris-
NaCl-Tween Buffer (TNT), overnight at 4
ο
C, followed by incubation with a biotinylated 
antibody against rabbit IgG (Jackson immunoresearch Laboratories) (1:400 in TNT, 45 min, 
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RT). Next, streptavidin–horseradish peroxidase was administered (1:100 in TNT, 30 min, RT). 
Finally, the reaction was amplified by tetramethylrhodamine-tyramide amplification reagent at 
RT for 5 min (1: 50 in amplification diluent provided in the kit).  
 
Apoptosis/proliferation assay 
In order to compare degree of proliferation and apoptosis of HFs in the two treatment groups, 
double immunolabelling of Ki-67 mouse anti-Ki-67 antiserum (DAKO, Hamburg, Germany) 
and TUNEL (ApopTag Fluorescein In Situ Apoptosisdetection kit; Millipore, Berlin, Germany) 
was performed as described previously (Bodo et al., 2004; Foitzik et al., 2000; Kloepper et al., 
2008; Peters et al., 2006). 
 
Melanin histochemistry 
In order to highlight the characteristic, catagen-associated switch-off of follicular 
melanogenesis (Stenn and Paus, 2001; Tobin et al., 1999), Masson–Fontana histochemistry 
was employed (Kloepper et al., 2010). Briefly, cryosections were air dried and fixed in 
ethanol-acetic acid. The sections were washed in TBS and distilled water several times. 
Cryosections were treated with ammoniacal silver solution (Fluka, Seelze, Germany) for 40 
min at 56
ο
C in the dark. After washing in distilled water, the sections were treated with 5% 
aqueous sodium thiosulphate (Merck, Darmstadt, Germany) for 1 min. Then, the sections 
were washed in running tap water for 3 min and were counterstained with haematoxylin for 45 
seconds. After washing in distilled water, sections were dehydrated and mounted in Eukitt (O. 
Kindler, Freiburg, Germany). 
 
Hair cycle staging 
Based on proliferation and apoptosis indices in combination with HF morphology and degree 
of pigmentation by Masson–Fontana staining, we determined the stage of each HF (anagen, 
early catagen, mid catagen, late catagen) and conducted the hair cycle score (HCS) of the 
two treatment groups, as described previously (Foitzik et al., 2006; Kloepper et al., 2010). For 
statistical analysis, anagen VI HFs were arbitrarily attributed a score of 100, HFs in early 
catagen a score of 200, in mid-catagen of 300 and in late catagen of 400. The sum of scores 
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per group was than divided by the number of investigated HFs (Foitzik et al., 2006). The 
mean value of these scores therefore is a reliable indicator of the mean HF stage that had 
been reached on average by a large population of HFs during organ culture. 
 
Quantitative (immuno)histomorphometry 
The immunoreactivity of the different immunohistology protocols and the relative blackness of 
Masson-Fontana stained sections was compared between test and control sections in well-
defined reference areas by quantitative histomorphometry, as previously described (Peters et 
al., 2005) using NIH IMAGE software (NIH, Bethesda, MD, USA). For this, the HF was divided 
anatomically into 4 reference compartments (outer root sheath (ORS); pre-cortical hair matrix 
(HM); innermost hair matrix (IHM); HM below Auber's line). 
 
HJMD patient histology 
Scalp skin sections stained with Hematoxylin Eosin (H&E) and hair shaft samples of one 5 
year old female HJMD patient, obtained for diagnostic purposes after informed consent in the 
context of an earlier study (Sprecher et al., 2001), were evaluated by light microscopy. Due to 
the extreme rarity of this syndrome and the difficulty to justify biopsy taking in these pediatric 
patients, this was the only histological sample available to us for analysis. 
 
Quantitative Real-Time PCR (Q-PCR) 
Q-PCR was performed on an ABI Prism 7000 sequence detection system (Applied 
Biosystems/Life Technologies, Foster City, CA, USA) using the 5’ nuclease assay as detailed 
in previous reports (Bodo et al., 2005; Dobrosi et al., 2008; Toth et al., 2009). Total RNA was 
extracted from whole organ cultured HFs using TRIreagent (Applied Biosystems/Life 
Technologies) and digested with recombinant RNase-free DNase-1 (Applied Biosystems) 
according to the manufacturer’s protocol. After isolation, 1μg of total RNA was reverse-
transcribed into cDNA by using High Capacity cDNA kit (Applied Biosystems) following the 
manufacturer’s protocol. PCR amplification was performed by using specific TaqMan primers 
and probes (Applied Biosystems, assay IDs: Hs00999915_m1 for human CDH3, 
Hs00610344_m1 for human axin2, Hs01547656_m1 for human IGF-1, Hs00427788_m1 for 
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KRT36, Hs01596219_g1 for KRT37 and Hs00263692_m1 for KRT84). As internal 
housekeeping gene controls, transcripts of glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), peptidylprolyl isomerase A (PPIA) or β-actin were determined (Assay IDs: 
Hs99999903 for human ACTB, Hs99999904 for human PPIA and Hs99999905_m1 for 
human GAPDH). The amount of the above mentioned transcripts was normalized to those of 
the control genes using the ΔCT method. 
 
Transmission Electron Microscopy (TEM) 
Representative P-cadherin siRNA and scrambled oligos treated HFs were fixed in 
Karnovsky’s fixative overnight at 4 ºC as previously described (Tobin et al., 1998), post-fixed 
in 1% OsO4 (0.1M phosphate buffer, pH 7.4) for 1 h, dehydrated in an ethanol series and 
embedded in Polybed (Polyscience, Warrington, Pa, USA). Semi-thin sections (0.5µm) were 
stained with toluidine blue and ultra-thin sections (0.1µm) were stained with saturated uranyl 
acetate and lead citrate and were examined using a Hitach H-7650 (Tokyo, Japan) electron 
microscope. 
 
Statistical analysis 
 All quantitative immunohistochemistry and HCS data were analyzed by Mann–Whitney test 
(GRAPHPAD PRISM version 4.00 for Windows; GraphPad Software, San Diego, CA, USA). 
Results are expressed as mean ± SEM. The results from only different highly comparable 
experiments using samples from different donors were pooled and statistical differences 
between groups were also determined by the Mann–Whitney test. 
All Q-PCR results were analysed by Student’s t test for unpaired samples. PCR results were 
normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH), peptidylprolyl 
isomerase A (PPIA) or β-actin.    
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Supplementary data for Figure legends 
  
Figure 2. Constitutive P-cadherin expression and P-cadherin knockdown in normal 
human hair follicles 
(g-h) Catagen induction after treatment with P-cadherin siRNA. The graphs represent data 
pooled from 3 independent experiments after one transfection; n=46-47 hair follicles (HFs) in 
each group. Hair cycle staging was assessed by Ki-67 staining, as well as by quantitative 
Masson-Fontana histochemistry. Data are presented as hair cycle score (HCS) (g) or as 
percentage of HFs in anagen VI, early, mid or late catagen (h). To calculate the HCS, each 
anagen VI HF was ascribed to an arbitrary value of 100, early catagen to 200, mid catagen to 
300 and late catagen to 400. Values were added per group and divided by the number of 
HFs. Thus, the score represents th  mean hair cycle stage of all HFs per treatment group. 
Significance refers to the HCS of control HFs (i.e. HFs treated with scrambled oligos after 4 
days of culture).  
 
Figure 5. P-cadherin knockdown increases degradation of β-catenin and reduces 
expression of β-catenin target genes 
Since P-cadherin silencing was conducted in microdissected hair follicles (HFs) which were 
isolated from the scalp skin prior to transfection, and not in skin/extrafollicular cell populations, 
the effect on β-catenin is restricted to cell population in the HF which expresses P-cadherin 
(innermost hair matrix). 
 
 
 
 
 
Page 78 of 91Journal of Investigative Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
7 
 
Supplementary Figures 
 
Supplementary Figure S1. Clinical and histological characteristics of HJMD patients  
(a) Both hypotrichosis with juvenile macular dystrophy (HJMD) and ectrodactyly and macular 
dystrophy (EEM) syndromes result from the same or similar mutations in the CDH3 gene. The 
patients are suffering from sparse and short hair as well as progressive macular degeneration 
leading to blindness during the second decade of life (Shimomura et al., 2008; Sprecher et 
al., 2001). In EEM, patients have an additional feature of ectrodactyly with split hand and foot 
malformation, while HJMD patients show normal limb development (Shimomura et al., 2010; 
Shimomura et al., 2008). The reasons for phenotypic disparity between HJMD and EEM 
syndromes are not known, although co-inheritance of a mutation in a neighboring gene such 
as CDH1 (encoding E- cadherin) or in modifier genes has been postulated (Kjaer et al., 2005; 
Shimomura et al., 2008). 
(b) Abnormal hair shaft of HJMD patient with pseudomonilethrix appearance and 
disorganized hair shaft cuticula. Pseudomonilethrix, pili torti, longitudinal ridging, and 
abnormal hair shaft scaling and folding are recognized in HJMD patients (Bergman et al., 
2004).  
(c) Scalp skin biopsy of HJMD patient (H&E) shows catagen (arrow) and vellus (arrow head) 
hair follicles (HFs) (H&E, magnification = x40). Insert demo strates absence of terminal HFs 
in the subcutaneous tissue.  
(d) Mid catagen HF of HJMD patient at high magnification (H&E, magnification = x400). The 
arrows point to karyorhexis, indicating HF dystrophy.  
DP – dermal papilla; SC - subcutaneous tissue; DR – dermis. 
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Supplementary Figure S1 
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Supplementary Figure S2. Normal P-cadherin expression in human epidermis and P-
and E-cadherin expression in human skin punches and hair follicles after P-cadherin 
knockdown 
(a) P-cadherin expression in normal human epidermis. The dotted line represents the dermal-
epidermal junction.  
(b-c) Reduced P-cadherin expression in the innermost hair matrix (IHM) of early catagen hair 
follicle (HF) (c) compared to normal anagen VI HF (b) which were directly microdissected 
from human intact scalp without any manipulation. Note the relative reduced melanin content 
in the HF pigmentary unit of the early catagen HF (c). 
(d-f) Reduced P-cadherin immunoreactivity (IR) in the epidermis of 2mm skin punches treated 
with P-cadherin siRNA (e), compared to scrambled oligos treated skin punches (d). 
**p<0.001, Mann Whitney test, n=6 (f). Note some remnant P-cadherin expression in the 
spinous layer of the epidermis following P-cadherin knockdown (e). Dotted lines encircle all 
epidermal layers, taken as reference area.  
(g) Reduced CDH3 mRNA level was demonstrated in P-cadherin siRNA treated skin 
punches. *p<0.05, Student’s t test for unpaired samples. 
 (h-j) No significant change in E-cadherin IR was found in transfected HFs (h). Dotted lines 
represent reference areas of measurement. Note the diffuse expression of E-cadherin in the 
human follicular keratinocytes, except in the IHM (j). 
IHM – innermost hair matrix; DP – dermal papilla; ORS – outer root sheath; HS – hair shaft; 
HM – hair matrix; IR – immunoreactivity; HFs – hair follicles; DEJ – dermal-epidermal 
junction; BL – basal layer; Scr – scrambled oligos; P-cad – P-cadherin. 
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Supplementary Figure S2 
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Supplementary Figure S3. P-cadherin knockdown results in keratin clumps inside 
pre-cortical hair matrix keratinocytes  
Ultrastructural analyses by Transmission Electron Microscopy of P-cadherin siRNA treated 
hair follicle (HF) (a, c, e) compared with scrambled oligos treated one (b, d, f).  
(a) Accumulation of massive keratin clumps inside the cytoplasm of the keratinocytes in the 
precortical hair matrix (white arrows). The white arrowheads indicate melanin granules inside 
a melanocyte in the HF pigmentary unit.  
(b) No evidence of keratin clumps in the precortical hair matrix keratinocytes of a scrambled 
oligos treated HF. White arrowhead indicates melanin granules inside a keratinocyte.  
(c-f) Demonstration of the precortical hair matrix region (c-d) in P-cadherin siRNA treated HF 
(c) and scrambled oligos treated HF (d), and of the proximal hair shaft (e-f) in P-cadherin 
siRNA treated HF (e) and scrambled oligos treated HF (f). The black arrowheads indicate the 
borderline between the cortex and the medulla of the hair shaft. Note the narrower 
intercellular space in P-cadherin siRNA treated HF compared to scrambled oligos treated HF.  
However, no difference was found in the appearance of both the cortex and the medulla.  
c – cortex; m – medulla. 
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Supplementary Figure S3 
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Supplementary Figure S4. Several hair keratins are upregulated by P-cadherin 
silencing 
Q-PCR analysis revealed upregulation of three specific hair keratins (KRT36/37/84) steady 
state transcript levels in P-cadherin silenced hair follicles (HFs) compared to scrambled oligos 
treated HFs, in three different patients, both after one and two transfections with P-cadherin 
siRNA vs. scrambled oligos. The graphs represent the results in one representative patient for 
each hair keratin mRNA level. All the three keratins were statistically significant upregulated in 
the three patients, except one patient that did not show significant upregulation of KRT36. 
***p<0.001; **p<0.01, Student’s t test for unpaired samples. 
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Supplementary Figure S5. Transforming growth factor beta (TGFβ)-neutralizing 
antibody partially restores the effects of P-cadherin silencing on human hair growth 
(a) Hair shaft elongation measurements of P-cadherin siRNA, P-cadherin siRNA + 
transforming growth factor β (TGFβ) neutralizing antibody (NA), and hair follicles (HFs) 
treated only with TGFβ NA;  compared to scrambled (Scr) oligo-treated HFs. ***p<0.001, 
**p<0.01, Mann–Whitney test, n=12-21.    
(b) Photodocumentation of one characteristic HF per group over a culture period of 4 days. 
(c) Hair cycle score corresponding to (b). ***p<0.001, **p>0.01, Mann–Whitney test, n=12-21.   
(d) Ki-67 analysis of hair matrix corresponding to (b). ***p<0.001, Mann–Whitney test, n=12-
21. 
NA – neutralizing antibody; TGFβ2 - transforming growth factor beta 2; Scr – scrambled; P-
cad – P-cadherin. 
 
 
 
 
 
 
 
Page 86 of 91Journal of Investigative Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
15 
 
 
 
Supplementary Figure S5 
Page 87 of 91 Journal of Investigative Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
16 
 
Supplementary Figure S6. No significant change in intraepidermal β-catenin 
expression following P-cadherin silencing 
(a) β-catenin immunoreactivity (IR) in P-cadherin siRNA treated 2mm skin punches. Dotted 
line represents the dermal-epidermal junction.  
(b) β-catenin IR in scrambled oligos treated 2mm skin punches. Dotted line represents the 
dermal-epidermal junction.  
(c) No significant change was observed in intraepidermal β-catenin expression of 2mm skin 
punches treated with P-cadherin siRNA compared to scrambled oligos treated ones.  
IR – immunoreactivity. 
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Supplementary Figure S7. Normal P- and E-cadherin expression in human breast 
tissue 
(a) P-cadherin positive immunoreactivity (IR) in the myoepithelial cells and negative IR in the 
luminal epithelium, in normal breast tissue as positive and negative control.  
(b) E-cadherin positive IR in both the myoepithelial and the luminal cells in normal breast 
tissue as a positive control.  
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